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The design and production of novel wound dressings that address resistance of microorganisms to 
antimicrobial agents, has attracted considerable attention. The ability to produce polymers with specific 
characteristics for specific applications offers a wide variety of options for application in the biomedical 
field, especially polymers that exhibit antimicrobial behaviour.  
This thesis is thus committed to the design, synthesis and characterisation of a bi-layered wound dressing, as 
well as antimicrobial evaluation of the final product. The bi-layered wound dressing consists of a component 
that maintains a favourable moist wound environment and a second component that addresses microbial 
infection. For the component that maintains the favourable moist wound environment two hydrogels will be 
created and electrospun. For this study the hydrogels were chosen to be sodium alginate, a hydrogel already 
in use for wound dressings, as well as a hydrogel from poly(styrene-alt-maleic anhydride) (SMA). For the 
antimicrobial component, quaternary ammonium salts were synthesised, as these are known to have 
antimicrobial properties. SMA is a biocompatible and commercially available copolymer that can easily 
undergo chemical modification through the highly reactive maleic anhydride residues and therefore is an 
attractive polymer for the production of hydrogels and antimicrobial polymers. SMA was synthesised by 
conventional free radical chemistry, followed by modification to yield a hydrogel as well as modification of 
SMA to yield two quaternary ammonium salts, exhibiting antimicrobial activity.  
SMA was electrospun and treated with a heat-activated crosslinking agent, namely diethylene glycol, to yield 
a nanofibrous hydrogel. A second nanofibrous hydrogel was also created from a natural polymer, namely 
sodium alginate. SMA was also treated with 3-(N,N-dimethylamino)propyl-1-amine (DMAPA), a compound 
with both a primary and tertiary amine, to yield poly(styrene maleimide) (SMI). SMI was then treated with 
two alkyl halides (1-bromooctane and 1-bromododecane) to yield quaternary ammonium compounds (qSMI) 
that shows antimicrobial activity. The quarternised SMI is then also electrospun to yield an antimicrobial 
nanofibrous layer and heat treated to render the fibres insoluble in water and organic solvents. The bi-layered 
wound dressing is produced by electrospinning one layer on top of the other in the case of the SMA 
hydrogel, followed by heat treatment to render the fibres insoluble. In the case of the alginate hydrogel, 
qSMI is electrospun and heat treated, followed by electrospinning of alginate on top of the qSMI layer.  
The individual electrospun fibre mats as well as the bi-layered system are subjected to antimicrobial 
evaluation by means of confocal fluorescence microscopy as well as zone inhibition on agar plates. The 
organisms used for the antimicrobial evaluation were Staphylococcus aureus, a Gram-positive bacterium, 
and Pseudomonas aeruginosa, a Gram-negative bacterium. Confocal imaging and zone inhibition revealed 
that qSMI containing the C12 aliphatic side chain showed a greater antimicrobial activity towards S. aureus 
as compared to C8. In the case of P. aeruginosa it was not clear which of the C8 or C12 containing qSMI 
fibres showed greater antimicrobial activity, however confocal imaging and zone inhibition revealed that 
both showed antimicrobial activity towards P. aeruginosa. 
 





Die ontwerp en vervaardiging van oorspronklike wondbedekkings wat die weerstand van mikro-organismes 
tot antimikrobiese middele aanspreek geniet aansienlike navorsingsaandag. Die vermoë om polimere met 
spesifieke eienskappe vir spesifieke toepassings te vervaardig bied `n wye verskeidenheid opsies vir 
aanwending in die biomediese veld, veral vir polimere wat antimikrobiese eienskappe het. 
Hierdie tesis is gerig op die ontwerp, sintese en karakterisering van `n dubbellaag wondbedekking en die 
ondersoek van die antimikrobiese eienskappe van die eindproduk. Die dubbellaag wondbeddekking bestaan 
uit `n komponent wat `n gunstige vogtige wondomgewing handhaaf en `n tweede komponent wat mikrobiese 
infeksie aanspreek. Vir hierdie studie is twee jel matrikse gekies om die gunstige vogtige wondomgewing te 
handhaaf, naamlik natrium alginaat, `n jel matriks wat reeds as wondbedekking gebruik word, en  
poli(stireen-alt-malaïene anhidried) (SMA) as die tweede jel matriks. SMA is `n  biologies-versoenbare 
kommersieël beskikbare kopolimeer wat maklik chemiese modifikasie ondergaan deur sy hoogs reaktiewe 
maleïene anhidried groepe en is dus `n aantreklike polimeer vir die vervaardiging van jel matrikse en 
antimikrobiese polimere. SMA is deur konvensionele vrye radikaal chemie gesintetiseer, gevolg deur 
wysiging om `n jel matriks te vervaardig, sowel as wysiging van SMA om `n kwaternêre ammonium sout 
wat antimikrobiese aktiwiteit toon, te vervaardig. 
SMA vesels is voorberei en behandel met `n hitte geaktiveerde bindingsagent, naamlik di-etileenglikol, om 
`n nano-veselagtige jel matriks te vorm. `n Tweede nano-veselagtige jel matriks is uit  `n natuurlike 
polimeer, naamlik natrium alginaat, vervaardig. SMA is ook met 3-(N,N-dimetielamino)propiel-1-amien 
(DMAPA), `n molekule met beide `n primêre en tersiêre amien, behandel om poli(stireen maleïmied) (SMI) 
te vervaardig. SMI is gevolglik met twee alkielhaliede (1-bromo-oktaan en 1-bromododekaan) behandel om 
kwaternêre ammonium molekules (qSMI) wat antimikrobiese aktiwiteit toon, te vervaardig. Vesels is dan 
ook uit die qSMI vervaardig om `n nano-veselagtige laag te maak wat dan met hitte behandel is om die 
vesels onoplosbaar te maak in water en ander organiese oplosmiddels. Die dubbellaag wondbedekking word 
vervaardig deur een vesellaag op die ander te spin in die geval van die SMA jel matriks, gevolg deur hitte 
behandeling om die vesels onoplosbaar te maak. In die geval van die natrium alginaat jel matriks is die qSMI 
laag eerste vervaardig, met hitte behandel, gevolg deur vesel vervaardiging van die alginaat bo-op die qSMI-
laag. 
Die onderskeie veselagtige matte en die dubbellaag sisteem is dan aan antimikrobiese evaluering blootgestel 
deur middel van konfokale fluoressensie mikroskopie, sowel as sone inhibisie op agar plate. Die organismes 
wat ondersoek is, is Staphylococcus aureus, `n Gram-positiewe bakterium, en Pseudomonas aeruginosa, `n 
Gram-negatiewe bakterium. Konfokale besigtiging en sone inhibisie het aangedui dat qSMI met die C12 
alifatiese syketting `n groter antimikrobiese effek op S. aureus het in vergelyking met die C8 syketting. Vir 
P. aeruginosa was dit nie duidelik watter van die C8 of C12 syketting qSMI vesels beter antimikrobiese 
aktiwiteit getoon word nie, maar konfokale besigtiging en sone inhibisie het wel getoon dat beide 
antimikrobiese aktiwiteit teen P. aeruginosa besit. 
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Chapter 1: Prologue 
1.1. Introduction 
The emergence of microbes with resistance to antimicrobial agents is of great concern to all of us. It is 
especially problematic in a medical setting as surgical site infections (SSIs) has been reported as the most 
common healthcare-associated infection for 2010 in the USA and therefore demands the prevention of 
microbial infection in this setting. Research into novel antimicrobial dressings and antimicrobial polymeric 
materials has notably increased in order to provide alternatives to antimicrobial agents that already show 
resistance. This may include the incorporation of known antimicrobial agents or the inclusion of naturally 
occurring antimicrobial substances into fibrous or other polymeric materials. Common agents already 
incorporated into wound dressings include silver, iodine and antiseptic agents like polyhexanide. Some 
disadvantages are however associated with current approaches, like diminishing effectiveness over time seen 
in continuous release of low molecular weight antibacterial agents from antibacterial matrices. Some 
antimicrobial agents may also be cytotoxic to human cells. 
The ability of scientists to create polymers for specific applications thus allows for the design of wound 
dressings that may address more than one area of interest. Historically wound management consisted of a 
natural or synthetic wound dressing like gauze or cotton wool. These maintained a dry wound environment 
that was found to be less favourable for wound healing due to wounds dressed with gauze or cotton wool 
being more susceptible to microbial invasion, painful upon removal as these dressings often adhere to the 
wound and may thus cause trauma to the wound bed when removed. Today modern wound dressings are 
designed to maintain a more favourable moist wound environment that minimises microbial infection, 
increases healing rates, reduces pain and ease of overall healthcare.  
Electrospinning is a simple and cost-effective technique that can be used to produce polymer nanofibres or 
composites. Nanofibres produced by electrospinning have a high surface to volume ratio, an advantage that 
enables the use of nanofibres in biomedical applications like wound dressings. Post-spinning modification of 
nanofibres is also possible, further increasing the attraction of the electrospinning technique for use in wound 
dressing applications.  
 
1.2. The aim and objectives of this work 
The aim of this study was to develop a bi-layered wound dressing, utilising the single needle electrospinning 
technique, which contains a non-leaching permanently antimicrobial polymer layer as well as a second 
hydrogel layer that will be able to maintain a moist wound environment. 
The main objectives of the study can be summarised as follows: 
a) To synthesise the SMA copolymer by conventional free radical chemistry. 
b) To modify SMA by reaction with a primary amine to yield the SMI precursor and subsequent 
reaction with a alkylhalide to yield a quaternary ammonium (qSMI). 
c) To create and electrospin a hydrogel as well as the qSMI to yield the bi-layered system. 
d) Microbial evaluation of the qSMI antimicrobial polymers as well as the bi-layered system. 
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1.3. Thesis layout 
Chapter 1 ˗ Prologue 
Chapter 1 gives a brief insight into the need for development of wound dressings that are able to address 
microbial invasion as well as maintain favourable conditions for wound healing. The aim and objectives of 
the study are also presented. 
Chapter 2 ˗ Literature review 
A comprehensive literature review of the types of wound dressings that is available for medical use, as well 
as antimicrobial agents is presented.  
Chapter 3 ˗ Synthesis, characterisation and modification of SMA 
Chapter 3 describes the methods employed to synthesise SMA. Subsequent modification and characterisation 
of the relevant polymers are also discussed. 
Chapter 4 ˗ Electrospinning and hydrogel formation 
Chapter 4 is dedicated to the formation of two hydrogels in fibrous form, one from SMA and one from 
sodium alginate. The electrospinning of qSMI and the production of the bi-layered system is also presented. 
Chapter 5 ˗ Antimicrobial evaluation 
Chapter 5 presents the evaluation of the antimicrobial activity of all electrospun fibres using confocal 
fluorescence imaging as well as the zone inhibition method. 
Chapter 6 ˗ Epilogue 
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Chapter 2: Literature review 
2.1. Introduction 
We all remember scraping a knee playing in a tree or falling with your bicycle as a child and your mother 
dressing your wound with some gauze or cotton wool and a bandage. During 2010 in the USA it has been 
reported that an estimated 16 million operative procedures were performed in acute care hospitals
1
, of which 
surgical site infections (SSIs) were the most common healthcare-associated infections, accounting for 31% 
of all healthcare-associated infections among hospitalised patients
1
. Though most of these are minor skin 
infections, more serious cases of SSIs are associated with a mortality rate of 3%, and 75% of SSI-associated 
deaths are directly attributable to the SSI. This is due to microbes becoming more and more resistant to 
antibiotics, like the commonly known Methicillin-resistant Staphylococcus aureus or MRSA. Surgical site 
infections also occur in 2-5% of all surgical procedures and in 5-12% of caesarean deliveries
2
.  
According to Statistics South Africa
3
, the number of deaths due to complications from surgery (which 
includes secondary infections) was reported to be between 4-8% of all deaths in 2013. Figure 2.1 shows a 
graphical representation of the causes of deaths in South Africa during 2013.  
 




Post-operative care is thus important in terms of early detection of post-operative complications, hygiene and 
overall ease of wound care.  
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2.2. Wound dressings 
Wound dressings form an integral part of the global medical and pharmaceutical industries. Historically, 
wound management was associated with the use of natural or synthetic materials such as gauze, cotton wool 
and lint as wound dressings. The primary function of these wound dressings was to keep the wound dry, 
allowing evaporation of the wound exudate and preventing pathogenic bacteria to enter the wound
4
. The use 
of gauze, cotton wool and lint as wound dressings are not of common practice today as some disadvantages 
are associated with their use, including
5
: 
 the inability of these materials to prevent microbial invasion 
 leads to trauma at the time of removal as these dressings adhere to the surface of the wound 
 it has low absorption ability leading to the accumulation of wound exudates which then become 
favourable environments for microbial attack 
 they do not allow proper permeability of gases 
 are only useful for minor wounds 
 and provide a dry wound environment.  
More recently it has been found that a moist wound environment has been associated with increased healing 
rates, improved cosmesis, reduced pain, less infection and ease of overall health care
6
. 




a) able to maintain a moist wound environment around the wound, preventing wound drying 
b) removes excess wound exudate, preventing saturation of the dressing to its outer surface 
c) permits thermal insulation  
d) controls pH 
e) allows gaseous diffusion 
f) conforms to the wound surface 
g) ability to facilitate debridement if so required 
h) minimizes scar formation 
i) provides mechanical protection 
j) is impermeable to extraneous bacteria and does not contaminate the wound with foreign particles 
k) is non-fibre shedding 
l) non-toxic and non-allergenic 
m) is non- adherent, comfortable and conforming as well as easy to remove 
n) minimises pain from the wound 
o) is cost-effective and cosmetically acceptable 
p) stimulates growth factors 
q) biocompatible  
Classification of wound dressing can be done in numerous ways; depending on the function of the dressing 
on the wound (for example debridement, antibacterial, occlusive, absorbent, adherence)
11
, the type of 
material used for the production of the dressing (for example hydrocolloid, alginate, collagen)
12
 as well as 
the physical form of the dressing (ointment, film, foam, gel). Table 2.1 summarises the types of wound 
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Table 2.1: Wound dressing types and their description from Zahedi et al
13
 
Dressing type Product name Description 
Passive Gauze Gauze is manufactured as bandages, sponges, tubular 
bandages, and stocking. Guaze may adhere to the wounds and 
disrupt the wound bed when removed, causing trauma to the 
wound bed. Therefore, these are suitable for minor wounds. 
 Tulle Greasy gauzes consisting of Tulle gauze and petroleum jelly 
does not stick to the wound surface and is suitable for a flat 
and shallow wound with minimal to moderate exudates. 
Interactive Semi- permeable films Semi-permeable, polyurethane membrane which has acrylic 
adhesive. These are transparent allowing easy wound check 
and are also suitable for shallow wounds with low exudate. 
 Semi- permeable foams Soft, open cell, hydrophobic, polyurethane foam sheet 6-8 mm 
thick. These dressings are designed to absorb large amounts of 
exudate and are therefore not suitable for low exuding wounds 
as they will cause dryness and scabbing. 
 Amorphous hydrogels Amorphous gels are not crosslinked. They are used for 
necrotic or sloughy wound beds to rehydrate and remove dead 
tissue. They are not used for moderate to heavily exuding 
wounds. 
Bioactive Hydrocolloids These are semi-permeable polyurethane films in the form of 
solid wafers; contain hydroactive particles such as sodium 
carboxymethyl cellulose that swells with exudate or forms a 
gel. Depending on the hydrocolloid dressing chosen they can 
be used in wounds with light to heavy exudate, sloughing, 
granulating wounds.  
 Alginates Calcium alginate which consists of an absorbent fibrous fleece 
with sodium and calcium salts of alginic acid (ratio 80:20). 
They are good for exuding wounds and helps in debridement 
of sloughing wounds. They are not used on low exuding 
wounds as this will cause dryness and scabbing. These 
dressing should be changes daily. 
 Collagens Collagens are dressings which come in pads, gels or particles 
and promote deposition of newly formed collagen in wound 
bed. They absorb exudate and provide a moist wound 
environment. 
 Hydrofibres Hydrofibres are soft nonwoven pad or ribbon dressings made 
from sodium carboxymethyl cellulose fibres. They absorb 
exudates and provide a moist environment in a deep wound 
that needs packing. 
 
The more modern wound dressings have been developed with their essential characteristic being to retain 
and create a moist wound environment. These are mainly classified according to the materials used to 
produce the dressings and a few of the more common dressings are discussed below. 
2.2.1. Hydrocolloid dressings 
Hydrocolloid dressings are bioactive wound dressings that describe a number of wound management 
products obtained from a combination of colloidal materials (gel forming agents like carboxymethyl 
cellulose, gelatin and pectin) in combination with materials such as elastomers and adhesives. These are 
bonded to a carrier of semi-permeable film or foam sheet in order to produce a flat, occlusive, adhesive 
dressing that will form a gel on the wound surface and promote moist wound healing
10
.  Typically, they 
occur in the form of thin films, sheets or composite dressings in combination with materials such as 
Stellenbosch University  https://scholar.sun.ac.za





. Hydrocolloid dressings are among the most commonly used dressings in practice
4
 due to their 
ability to adhere to both moist and dry wound sites. When intact, these dressings are impermeable to water 
vapour, but when the wound exudate has been absorbed it forms a soft coherent gel
10
 that covers the wound 
and promotes moist wound healing
4, 10
. This is especially useful for the rehydration of dry necrotic 
eschar
10
making these dressings suitable for light to moderately exuding wounds.  
Generally the occlusive nature of the hydrocolloid dressings is beneficial however, it can be disadvantageous 
to use in the case of infected wounds that require a certain amount of oxygen for rapid healing
4
. The use of 
hydrocolloid dressings in infected wounds is thus questionable due to the hypoxic and excessively moist 
wound environment that may cause autolysis of necrotic tissue, increasing the risk of infection
8
. The fibrous 
nature of these dressings may also act in a disadvantageous manner as some fibres can be deposited into the 
wound. The fibres will have to be removed during dressing change which can be painful
4
. Hydrocolloid 
dressings may also produce a distinctive odour in some cases due to the product breakdown
7
. This may also 
be mistaken for infection
10
.  
2.2.2. Alginate dressings 
Alginate or alginic acid is one of the most extensively researched and applied natural polymers in tissue 
engineering and drug delivery systems. Its abundance in nature as a structural component found in a family 
of marine brown algae (Phaeophyceae)
 8, 10
 and as capsular polysaccharides in some soil bacteria makes it an 
attractive polymer for research. This polysaccharide is comprised of mannuronic (M-residues) and guluronic 
(G-residues) acid residues which are covalently linked in alternating or random sequences
8 
as seen in Figure 
2.2.  
 
Figure 2.2: Chemical structure of the repeating units found in alginates: (I) L-guluronic acid (G); (II) 
D-mannuronic acid (M); (III) alternating L-guluronic and D-mannuronic acids (GM)
14
 
Alginates have the ability to form reversible hydrogels: the product of ionic interactions of alginate with 








. Ionic interaction causes crosslinking of the G-residues of 
adjacent alginate chains
8
. The major reason for alginate’s appeal as a wound dressing is due to the ability of 
crosslinked alginate to form gels when in contact with wound exudates
4
. Alginate also has high absorption 
ability through hydrophilic gel formation, thereby limiting wound secretions and minimising microbial 
contamination
4
. Depending on the amount of mannuronate or guluronic acid present in the alginate dressing 
different types of gels may form upon hydration: dressings rich in mannuronate will form soft flexible gels, 
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whilst dressings rich in guluronic acid will form a firmer gel. The relative amount of mannurinate and 
guluronic acid also influences the amount of exudate that will be absorbed
10
 by the wound dressing. 
Alginate partially dissolves on contact with the wound fluid, forming a hydrophilic gel. This is a result from 
the exchange of sodium ions present in the wound fluid with the calcium ions present in the dressing
10
. The 
exchange creates a slow degrading gel that maintains an optimum wound environment in terms of moisture 
content and healing temperature
4
. The gel formed from alginate dressings high in mannuronic acid can be 
removed simply by washing with a saline solution, whilst those dressings high in guluronic acid tend to keep 
their structural integrity and may be removed in one piece
10
.  
Alginate dressings are useful in the case of moderate to heavily exuding wounds, but should be used with a 
secondary dressing, like a hydrocolloid or foam, to prevent drying out of the dressing
7
. One of the other 
advantages in the use of alginate dressings is that they can be used in infected or non-infected wounds, the 
latter requiring a non-occlusive secondary dressing
7
. The use of alginate dressings is however limited to 
exuding wounds as they require moisture (obtained from the wound exudate) in order to function effectively. 
As the primary function of alginate dressings is to maintain a moist wound environment by forming a gel 
from the wound exudate, the use of alginate dressings on dry wounds or wounds covered with hard necrotic 
tissue could dehydrate the wound and inevitably delay healing
4
. The dressing may also adhere to the wound 
bed, causing damage to the healing tissue and pain upon removal
10
.  
2.2.3. Hydrogel dressings 
Hydrogel dressings are insoluble, swellable hydrophilic materials made from natural
5
 as well as synthetic 
polymers
4
, mostly used for the maintenance of highly moist wound environments
8
 as they possess excellent 
tissue compatibility and have most of the characteristics needed in an ideal wound dressing
5
. The ability of 
these crosslinked materials to entrap large amounts of water (70-90 %)
4
 and maintain a moist wound 
environment required for an ideal dressing
5
 heeds their attraction as wound dressings. Crosslinking, whether 
it is covalent or non-covalent, allows the control of swelling capacity, maintenance of the conformational 
structure and the reversible swelling or shrinking in pH specific aqueous environments and ionic strength 
values
8
.  Hydrogel dressings are able to transmit moisture vapour and oxygen, however bacterial and fluid 
permeability is dependent on the secondary dressing used in combination with the hydrogel
10
. Hydrogels can 
be applied as an amorphous gel or in the form of an elastic, solid sheet or film
4
 and are useful in the case of 
wounds with minimal to moderate exudate
7
. 
The transparent nature of hydrogels allows one to monitor the wound without removal of the dressing. The 
flexible nature of hydrogel sheet dressings allows one to cut them to better fit around a wound
4
. The sheet 
dressings also do not require a secondary dressing as the transmission of water vapour through the dressing is 
controlled by a semi-permeable polymer film backing
4
. The poor mechanical properties of hydrogel 
dressings after swelling constitute their main disadvantage
5
.  This makes them difficult to handle and has 
been noted to affect patient compliance
4
. The poor mechanical properties of hydrogels can be overcome by 
incorporating composite materials like where a textile material is coated with a polymer solution
5
. Another 
drawback is the accumulation of fluids around the wound which can lead to maceration of the skin and 
bacterial proliferation, producing a foul smell in infected wounds
4
 and leads to healing problems
8
.  
2.2.4. Foam dressings 
Developed as an alternative to hydrocolloid dressings
8
, foam dressings consists of either a porous 
polyurethane foam or film
4, 7, 10 
or can also be a silicone based foam
4, 7, 10
. They are highly absorbent due to 
their porous nature and thus capable of handling high volumes of wound exudate
7
, like in the case of 
moderate to heavily exuding wounds
4, 8, 10
. The capacity of wound exudate that can be absorbed by foam 
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.  Polyurethane foams consist of up to three layers, including a hydrophilic surface that is in contact 
with the wound, a hydrophobic backing
10
 and an occlusive polymeric layer to prevent bacterial 
contamination and loss of fluids
4
. Silicone foams on the other hand, consist of a silicone elastomer prepared 




Foam dressings are semipermeable
7














and can conform to body surfaces
8
. Silicone foams have the added advantage of protecting the surrounding 
wound area from further damage
10
 as the silicone foam fits into the wound shape. The absorbent and 
protective nature of foam dressings also allow for them to be left on the wound for up to seven days
8
.  
Foam dressings are not suitable for use in the case of dry epithelising wounds or scars as their ability to 
achieve an optimum moist wound healing environment is reliant on wound exudates
4
.  
2.2.5. Antimicrobial dressings 
The application of antibiotics and antibacterial agents helps with prevention or combat of infections, like in 
the case of diabetic foot ulcers, surgical and accident wounds as infection rate may be high due to reduced 
immune resistance response as a result from extreme trauma
4
. In cases like these the use of a dressing that 
contains and maintains a continuous release of antimicrobial agents at the wound site may be beneficial. 




Often systemic administration of antimicrobial agents result in toxic reactions such as cumulative cell and 
organ toxicity of aminoglycosides in the ears and kidneys
4
 due to high antibiotic doses needed to achieve 
sufficient systemic efficiency. Delivering antibiotics directly to the infected area may therefore be more 
beneficial in order to avoid complications (like organ toxicity) due to systemic administration
4
. In essence, 
using antimicrobial dressings that can deliver antimicrobial agents directly to the wounds may provide better 
tissue compatibility, reduced occurrence of bacterial resistance and reduced interference with wound 
healing
4
. The risk of systemic toxicity may also be lowered as lower doses of antibiotics are applied within 
dressings. Additionally, localised antibiotic delivery may overcome ineffective systemic antibiotic therapy 
due to poor blood circulation at the extremities, like in the case of diabetic foot ulcers
4
.  
The main goal when using antimicrobial dressings should always be the provision of an optimum wound 
environment to speed up healing. When selecting a suitable antimicrobial agent, the following should be 
considered: specificity and efficacy of the agent, cytotoxicity to human cells, potential to select resistant 
strains and allerginicity
7
. The more common antimicrobial agents currently used in antimicrobial dressings 
include products containing iodine, silver and antiseptic agents like polyhexanide
7
.  
Iodine is clinically commonly used in one of two forms, as povidone-iodine (an iodophor) and cadexomer 
iodine. Povidone-iodine is formed by the complexation of iodine with poly(N-vinylpyrrolidone) (PVP), an 
iodophor produced as impregnated tulle
10
. Cadexomer iodine is also formed by the complexation of iodine 
with a polymeric cadexomer
10
 starch vehicle to form a topical gel or paste
6
. When the wound exudate us 
absorbed by the cadexomer moiety, slow release of low concentrations of free iodine takes place, effectively 
reducing bacterial contamination in the wound and positively affects the healing process as compared to 
conventional treatments
6
. Caution should be taken if a patient has thyroid disease as systemic uptake of 
iodine is possible
10
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Silver, in ionic or nanocrystalline form, has been used as an antimicrobial agent for many years, particularly 
in the treatment of burns in the form of silver sulfadiazine cream
10
. The incorporation of silver into 
semiocclusive dressings like foams, hydrocolloids, alginates and hydrofibers
6
 has broadened its use in other 
types of wounds that are colonised or infected
10
. As these products come into contact with or absorb wound 
exudate they release silver cations into the wound
6
.  
2.3. Antimicrobial agents 
Long before a proper understanding of the mode of action of antimicrobial agents, disinfectants and 
antiseptics were commonly used. This is due to the simple observation that the spoiling of meat and rotting 
of wood was curbed by certain substances. The term “antiseptic” was first used in 1750 to describe 
substances that prevent decay
15
. Eventually this idea would be applied to the treatment of wounds. It was not 
however until the nineteenth century that the use of antiseptics became general practice as a man named 
Lister would eventually bring about the use of antiseptics in surgical practice by 1870
15
. He would use a 
2.5% solution of phenol for dressing wounds and a 5% solution of phenol to sterilise surgical equipment, 
also applying phenol vigorously during surgery. He would later use a phenol spray to produce a sterile 
environment for surgical operations to be carried out
15
. This was a great step forward for surgery as wounds 
would regularly become infected and a high mortality rate reigned. This antiseptic era in surgery gave rise to 
the aseptic era, where the focus now is to avoid bacterial contamination rather than killing bacteria. The 
infection of surgical wounds is still a constant risk and antiseptics are still used as a second line of defence.  
2.3.1. Antifungal agents 
During the past two decades resistance to antibacterial and antifungal agents has grown significantly. The 
gravity of antimicrobial resistance is great in terms of the implications it has on morbidity, mortality and 
health care costs. Considerable attention has thus been spent to have a detailed understanding of 
antimicrobial resistance mechanisms, improved methods to detect resistance, innovative antimicrobial 
treatment of infections caused by resistant organisms, as well as simple methods to prevent the increase and 
spread of resistance
16
.  An understanding of antimicrobial resistance by all types of microbes are important, 
however antibiotic resistance in bacteria have enjoyed considerable research attention for several reasons: a) 
the bulk of community-acquired and nosocomial infections are as a result of bacterial infections; b) the large 
and ever increasing number of antibacterial classes offers a more diverse range of resistance mechanisms to 
study; and c) the ability to move bacterial resistance determinants into well-characterised bacterial strains 
facilitates the detailed study of molecular mechanisms of resistance in bacterial species
16
. 
For a period of almost 40 years, the only drug available for the treatment of serious fungal infections was 
amphotericin B
16, 17
. Unfortunately, this drug was known to cause significant nephrotoxicity
16
. It wasn’t until 
the late 1980s and early 1990s that other drugs were approved, namely the imidazoles and triazoles. The 
imidazoles and triazoles introduced a safe and effective treatment of local and systemic fungal infections
16
. 
The triazoles, particularly fluconazole, have been used extensively for the treatment of fungal infections due 
to their high safety profile. Unfortunately, due to the extensive use of fluconazole reports of antifungal 
resistance are also increasing, thus necessitating to the need for a better understanding of resistance to 
antifungal agents. Resistance to antifungal agents has been less focussed on than antibacterial resistance for 
several reasons, the most important probably due to fungal diseases not being recognised as important 
pathogens until relatively recently. The annual death rate due to fungal infections for the period 1950-1970 
was relatively steady, however, since 1970 the death rate increased
16
 as changes in medical practices also 
came about. Changes in medical practices that contributed to the increase in death rate as a result of fungal 
infections include widespread use of immunosuppressant therapies, frequently using broad-spectrum 
antibacterial agents unselectively, common use of indwelling intravenous devices and the advent of chronic 
immunosuppressive viral infections like acquired immunodeficiency syndrome (AIDS)
16
. The increasing 
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severity and frequency of fungal infections is of great concern, particularly in patients with impaired 
immunity. 
Many fungal infections are caused by opportunistic pathogens that are already present in or on the body or 
acquired from the environment and can be classified into a) allergic reactions to fungal proteins, b) toxic 
reactions to toxins present in certain fungi and c) infections or mycoses
18
. Aside from patients suffering from 
AIDS, invasive fungal infections and dermatomycoses are common in individuals that are more susceptible 
to infection such as neonates, cancer patients receiving chemotherapy, organ transplant patients and burn 
patients. The risk of fungal infection increases with treatment with corticosteroids and antibiotics, diabetes, 








The complex nature of fungal cells allow for multiple targets for antifungal therapy (Figure 2.3)
17
. One of 
these targets is fungal ergosterol synthesis inhibitors, like the azoles
17-19
. Ergosterol, the major component of 
the fungal cell membrane, is a bioregulator of membrane fluidity, asymmetry and integrity. It plays a 
hormone-like role in fungal cells, stimulating growth. Squalene epoxidase, an enzyme, together with 
squalene cyclase converts squalene to lanosterol. When lanesterol is inhibited it prevents the conversion of 
lanesterol to ergosterol.  
Ergosterol disruptors like polyenes antibiotics form a complex with ergosterol to disrupt the fungal plasma 
membrane, resulting in increased membrane permeability
19
, the leakage of the cytoplasmic contents like 
sodium, potassium and hydrogen ions
21
, inevitably causing death of the fungal cell. Polyenes, like 
amphotericin B, are fungicidal in nature and have the broadest spectrum of antifungal activity of clinically 
available agents. Amphotericin B has been the “golden standard” for fungal therapy since its introduction in 
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Another target for antifungal therapy is glucan synthesis inhibitors. The glucan polysaccharide plays an 
essential role in maintaining the physical properties of the cell wall. The blockage of glucan synthase 
ultimately causes lysis of fungal cells, as less glucose is incorporated into the glucan polymer
18
.  
Another important polysaccharide within the cell wall is chitin. Chitin plays an integral role in determining 
the shape of the cell, even though a small percentage of chitin is present in the fungal cell wall (less than 
1%), covalently linked to glucan in the cell wall, but well separated from the glucan. This essential polymer 




Another option for antifungal therapy is nucleic acid synthesis inhibitors, like flucytosine
19
. Initially 
developed as an anticancer drug, today it is used with Amphotericin B. It works as an antifungal agent by its 
conversion into 5-fluorouracil within the target cells which is incorporated into ribonucleic acid (RNA). This 
causes premature chain termination and further inhibits the synthesis of deoxyribonucleic acid (DNA) 
18
. 
Sordadins, which are absent from mammalian cells and the electron transport chain, are selective inhibitors 
of fungal protein synthesis by blocking the function of fungal translation. Lastly, the inhibition of 
microtubules synthesis also serves as an antifungal target. Microtubules are polymers consisting of α- and β- 
tubulin dimers, forming a highly organised cellular skeleton in all eukaryotic cells
18
. A detailed classification 
of antifungal agents in use today is summarised in Table 2.2. 
The known cytotoxicity of Amphotericin B has led to the development of more targeted topical fungal 
treatment
21
. Topical burn wound agents available as wound dressings include silver-coated dressings like 
silver sulfadiazine dressings, chlorhexidine acetate dressings and nystatin dressings
22
. Attempts into the 
development of Amphotericin B as a topical agent has also been investigated by Sanchez et al
21
, where 
nanoparticle encapsulated Amphotericin B was incorporated into a silane-based hydrogel nanoparticle 
platform for controlled drug release. Their system showed significant reduction in metabolic activity of the 
fungal biofilm ranging from 80-95 % reduction in viability. 
Conventional systemic or topical antifungal therapy in oral candidiasis often results in increased cytotoxicity. 
Cossu et al
23
 has therefore investigated the production of starch stabilised Pickering emulsions as delivery 
vehicles for the controlled release of antifungal agents. They produced Pickering emulsions of thymol, a 
natural phenolic compound that shows antifungal activity, as well as Amphotericin B. Calcium alginate films 
containing starch Pickering emulsions of thymol or Amphotericin B were then produced. Both showed 
antifungal activity, with Amphotericin B  requiring as little as 10 μg/mL for growth zone inhibition and 
thymol requiring 9000 μg/mL or higher for growth inhibition. 
Study into electrospun mats containing cyclodextrin polymers to act as wound dressings that show tunable 
release of incorporated fluconazole that form inclusion complexes was conducted by Costoya et al
24
. Before 
treatment of the cyclodextrin mats with hexamethyldisiloxane, burst release of fluconazole took place within 
30 min. Hexamethyldisiloxane coated fibers on the other hand released roughly 50 % of the fluconazole drug 
in the first 2 hours and showed a more sustained drug release up to 24 hours. Both the coated and uncoated 
mats showed activity against Candida albicans. 
A comparative study of a silver-coated dressing containing silver sulfadiazine, a chlorhexidine acetate 
dressing and a nystatin dressing was done on rat burn wounds. Acar et al
22
 found that nystatin dressings were 
the most effective against C. albicans-contaminated burn wounds and in the prevention of further infection 
into muscle tissue or systemic infection. The silver-coated dressing is a choice of treatment for fungal burn 
wound infection with an added antibacterial effect and it has the added benefit of requiring less frequent 
dressing changes. 
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Table 2.2:  Classification of antifungal agents
18
 






Fluconazole A Active against Candida spp. Gastrointestinal intolerance 
 Itraconazole A Anti- Aspergillus activity Fluid retention, left 
ventricular dysfunction, 
gastrointestinal intolerance 










Voriconazole A Invasive aspergillosis Elevation of transaminases 
and visual disturbances, rash 
and gastrointestinal 
symptoms 
 Posoconazole A Prophylxis of invasive 
aspergillosis and Candida 
infection 
Nausea, vomiting, headache, 
abdominal pain and diarrhea 
 Ravuconazole A Active against a wide range of 
fungi, including Candida spp., 
C. neoformans and other yeast 
species 
Gastrointestinal 
Echinocardin Caspofungin B Potent activity against 
Aspergillus spp., Oesophageal 
candidiasis 
Headache, fever, nausea, 
rash, phlebitis 
 Micafungin B Treatment of Oesophageal 
candidiasis 
Nausea, vomiting, headache, 
diarrhea, phlebitis and 
leukopenia 
 Anidulafungin B Active against Candida spp., 
Oesophageal candidiasis 
Hypotension, vomiting, 
constipation, nausea, fever, 
diarrhea, hypokalemia and 
elevated hepatic enzymes 
Antibiotics Nystatin C Superficial (mucosal) candida 
infections of the oropharynx, 




C Broad- spectrum of antifungal 
activity 
Nephrotoxicity, infusional 
toxicity, low blood potassium 





Flucytosine E Active against Candida and 
Aspergillus spp. 
Bone marrow toxicity 
Allylamine Terbinafine F Used for fungal nail infections Mild rash, nausea, loss of 
taste 
A = interact with cytochrome p-450; inhibit C-14 demethylation of lanosterol, thereby causing ergosterol depletion and 




 isomerase and the Δ
14
 reductase inhibition, C = 
glucan synthase inhibitors, D = interact with ergosterol, thereby disrupting the cytoplasmic membrane, E = inhibits 
thymidylate synthase and therby DNA synthesis, F = inhibit squalene epoxidase 
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2.3.2. Antibacterial agents 
The battle between humans and microbes that cause infection and disease has been a continual one 
throughout history and one still not won today. The availability of penicillin in the 1940s meant that major 
strides into the development of antibacterial drugs were made. Unfortunately, the common use of antibiotics 
led to bacteria developing more and more sophisticated resistance mechanisms.  
Antibacterial agents act by interfering with either the structure of bacteria or metabolic pathways in the 
bacteria
25
. Antimicrobial agents used for treatment of bacterial infections can be categorised according to the 
primary mechanism of action. Four major mechanisms (seen in Figure 2.4) have been identified to date, 
including 1) interference with the synthesis of the cell wall
25-27
 2) inhibition of protein synthesis
25-27
, 3) 
interference with nucleic acid synthesis
25-27




Figure 2.4: Major targets for antibacterial action
28
 
The bacterial cell wall is unique in that it contains peptidoglycan
25-29
 as structural component. It thus follows 
that this would be a sensitive site for selective attack
25-29
. Antibacterial drugs of the first class, namely those 
















β-lactams exhibit interference by interfering with the necessary enzymes for the synthesis of the 
peptidoglycan layer. The glycopeptides vancomycin and teicoplanin bind to the terminal D-alanine residues 
of the forming peptidoglycan chain, in so preventing the necessary crosslinking for a stable cell wall.  
The purpose of proteins within the bacterial cell is several fold, including maintaining the shape and 
structural integrity of the cell or acting as enzymes that control the metabolic activity of cells
29
. Those drugs 









, streptogramins and oxazolidinones. Bacterial and eukaryotic ribosomes are structurally 
different, therefore allowing antibacterial agents to take advantage of these structural differences in order to 
selectively inhibit bacterial growth. The different antibacterial agents that inhibit protein synthesis can either 
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bind to the 30S subunit of the ribosome (including macrolides, aminoglycosides and tetracyclines) or may 
bind to the 50S subunit of the ribosome (like chloramphenicol).  
The genetic information of all living cells is contained by the chromosomes and the area in a chromosome 
that contains a particular character is known as a gene
29
. Genes control the structure of all enzymes and the 
rates at which they are produced. Interfering with the production of essential enzymes will thus have 
detrimental effects for the bacterial cell. Interference with nucleic acid synthesis is achieved by the 
fluoroquinolones
25-28
 that disrupts DNA synthesis and causes fatal breaks in the double-strand DNA during 
replication. Other drugs utilising the mechanism of nucleic acid inhibition include the sulphonamides and 
trimethoprim which ultimately inhibit DNA synthesis by blocking the folic acid synthesis pathway.  
Another possible mechanism that may be included is the disruption of a specific membrane structure
27
; 
however this mechanism of action is not well defined. It is suspected that polymyxins have allows greater 
permeability of the bacterial membrane and causes the bacterial contents to leak from the membrane
27
. 
Depolarisation of the membrane and eventual cell death may also take place, like in the case of the cyclic 
lipopeptide daptomycin that inserts its lipid tail into the bacterial cell membrane
23
. 
The inclusion of antibacterial agents in wound dressings is of common practice today, with numerous 
options already available
4
 and studies into novel antibacterial dressings also on the rise. Topical antiseptic 
agents can also be used with more traditional wound dressings, like gauze, to prepare an antibacterial wound 
dressing. Common topical agents used include iodine-releasing agents, chlorine-releasing agents, hydrogen 
peroxide, chlorhexidine, silver-releasing agents and acetic acid
4
. Numerous wound dressings containing 
antibiotics are also available for use in infected wounds. The antibiotics already incorporated into wound 




Novel developments of antibacterial dressings have already brought interesting options to light. The work 
done by Namazi et al
30
 focussed on the design of a carboxymethyl cellulose hydrogel that incorporated 
mesoporous silica MCM-41 as a nano drug carrier. They then loaded the nanocomposite hydrogel system 
with tetracycline and methylene blue as antibacterial agents and found that the antibacterial agents showed 
an extended release profile due to the incorporation of the silica particles. 
Previous study has shown bacterial nanocellulose to be a possible suitable biomaterial that fulfils all 
requirements of an ideal modern wound dressing, the only drawback being its inactivity in terms of 
antimicrobial behaviour. Moritz et al
31
 has therefore functionalised bacterial nanocellulose with an antiseptic 
drug, namely octenidine. Their system showed a biphasic release profile of octenidine, with rapid release in 
the first 8 hours, followed by a more sustained release up to 96 hours. Their wound dressing system also 
showed antimicrobial activity against Staphylococcus aureus. Their product also proved to be stable, 
releasable and biologically active over a period of 6 months, presenting a wound dressing that is ready to 
use. Other investigations include a sponge-like nano Ag/ZnO-loaded chitosan composite dressing with high 
porosity and swelling that also showed enhanced blood clotting and antibacterial activity
32
. Singh et al
33
 
created hydrogel films based on acacia gum and carbopol meant for the slow release of the antibiotic drug 
gentamicin. In another study, He et al
34
 produced fibrous membranes of polyvinylidene fluoride loaded with 
enrofloxacin that also displayed a rapid release of the antibacterial drug within the first 12 hours, followed by 
sustained release for 3 days. Their product showed good antibacterial properties. The possibilities for novel 
wound dressings containing antibacterial agents are thus very diverse. 
2.3.3. Antiviral agents 
The virus, a simplistic living organism, consists of genetic material contained in a protein capsule known as a 
capsomer
35
. Although viruses lack a metabolic system, viruses are formidable adversaries in the human body 
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for several reasons. First of all, they have the ability to use their host’s cell processes for metabolism and 
replication
35
. They remain latent for years, with no antiviral drug currently available that can eliminate this 
viral latency
35
. Thirdly, their genetic material can change over time and this increases the risk of drug 
resistance
35
. Lastly, some viruses have the ability to penetrate into the central nervous system
35
. This is 
problematic as drugs and immune cells are often unable to reach these infections. Due to the parasitic nature 
of viruses, the use of a pharmaceutical agent that will kill or inhibit a virus is most likely to cause injury to 
the host cell.  
Currently, the aim of antiviral agents is to interfere with some part of the viral reproductive cycle
35
. The viral 
replication process that leads to disease symptoms have been described in six steps, namely adsorption, 
penetration, uncoating, replication, maturation and new viruses
35
. A virus attaches itself to a host cell 
(absortion) and enters the host cell by the process of endocytosis (penetration). The virus enters the cell wall 
of the host cell through an opening formed for the virus to enter. The opening closes again and traps the virus 
inside the cell. Once inside the host cell, the virus can now start the uncoating process where the virus opens 
its capsule or protein coat to expose its genetic material, ready for protein synthesis. The synthesised proteins 
are then used as either capsomers or enzymes that catalyse viral multiplication. Viral DNA is incorporated 
into the host cell’s chromosomes by an enzyme known as integrase. The host cell therefore produces new 
viral nucleic acid that is the template for protein synthesis. The viral protein is then hydrolysed into smaller 
subunits by a protease enzyme. During the maturation stage, capsomers and newly produced nucleic acids 
are assembled to yield a new virus. The final step is the release of the newly formed virus that ultimately 
leads to the destruction of the host cell. It is at this stage that disease symptoms occur
35
.  
Like mentioned before, antiviral agents interfere with some part of the reproductive cycle described above. 
Interference can be classified according to which stage of the replication cycle they affect
35
. They are a) 
uncoating inhibitors, b) nucleic acid synthesis inhibitors, c) nucleoside reverse transcriptase inhibitors, d) 
non-nucleoside reverse transcriptase inhibitors and e) protease inhibitors.  
Uncoating inhibitors binds to a viral protein capsule and concentrate in lysosomes
35
. Lysosomes exist as 
separate particles that contain hydrolytic enzymes that can break down proteins and certain carbohydrates 
within their limiting membrane. An increase in concentration of the antiviral agent within the lysosomes 
increases the lysosomal pH and ultimately interferes with membrane fusion, inhibiting the uncoating process 




 used in the 
treatment of influenza A. 
Nucleic acid synthesis inhibitors interfere with the synthesis of viral DNA or RNA
35
. For most of these 
antiviral agents to become active, they have to undergo phosphorylation (a process where they are changed 
to phosphates) by viral kinases. Once phosphorylation of the drug occurs it cannot cross the viral cell 
membranes, causing it to accumulate at high concentrations within the infected cells.  High concentrations of 
the phosphorylated drug inhibit DNA or RNA polymerases, terminate the DNA chain or suppress viral 
messenger RNA. Antiviral agents that inhibit viral activity according to this mechanism include: acyclovir 
used for the treatment of herpes virus
35-37
, ganciclovir and foscarnet used for the treatment of 
cytomegalovirus retinitis
35, 36




Nucleoside reverse transcriptase inhibitors (NRTI) exhibit a similar mechanism of action to the nucleic acid 
synthesis inhibitors described above
35
. These antiviral agents are phosphorylated by cellular kinases, forming 
phosphates that can inhibit viral reverse transcriptase and terminators of the viral DNA chain. This 
classification of antiviral agent is currently approved for the use in HIV treatment as HIV infection includes 
a component of reverse transcriptase. Examples of some of the described drugs include didanosine, 
lamivudine, stuvadine, zalcitabine and zidovudine
35-37
. Lamivudine is also an appropriate drug to use for 
treatment of hepatitis B
35-37
. 
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Nonnucleoside reverse transcriptase inhibitors (NNRTI) bind to HIV reverse transcriptase, disrupting the 
catalytic site to block viral reproduction
35
. These agents are less toxic than the NRTI as they do not inhibit 
human DNA polymerase. Unfortunately rapid drug resistance occurs and therefore they are administered in 
combination with other drugs. Examples of NNRTI are nevirapine and delavirdine
35-37
.  
Protease inhibitors inhibit proteolytic enzymes needed for the production of viruses in the cells
35
. Protease 




Wound dressings for antiviral applications are not as common as for antifungal or antibacterial applications. 
Silver sulfadiazine containing wound dressings have however shown some antiviral activity
38, 39
. 
2.3.4. Antiseptic agents 
The use of antiseptic agents is a common occurrence in our everyday life-from antibacterial soaps to 
waterless hand sanitizers. This common use of antiseptics in everyday objects has cause for great concern as 
this helps along the increase of resistance of microorganisms.  
Common antiseptic agents used include aldehydes (like formaldhyde and gluteraldehyde)
40
. Aldehydes may 
be occupationally hazardous, even at low concentrations
2
. Futhermore guanidines (like chlorhexidine, 
polyhexamethylene guanidine and polyhexamethylene biguanidine), benzalkonium compounds, ethylene 
oxide, triclosan, halogens (like sodium hypochlorite, tosylchloramide, iodophors and polyvinylpyrrolidone/ 
povidone and povidone-iodine) and phenolic compounds (like phenol and thymol/ methyl salicylate)
40
 are 
also commonly used antiseptics. 
Surgical site infections (SSI) are also common occurrence, with 2-5 % of all surgical procedures resulting in 
SSI and 5-12 % of caesarean deliveries resulting in SSI
2
. Caesarean delivery of babies is considered the most 
common surgical procedure among American women, accounting for 32.7 % of 3.9 million births in 2013
2
. 
Surgical site infection of course is costly and may impact mother-infant bonding, breastfeeding and cause 
extra stress for the new mother.  
Considering the skin is a major source of pathogens that cause SSI, effective preoperative skin treatment 
with antiseptic agents may decrease SSI. In a study comparing a chlorhexidine-alcohol combination with an 
iodine-alcohol combination found that the chlorhexidine-alcohol significantly lowered the risk of SSI after 
caesarean delivery when used as preoperative skin treatment
2
.  
The regular use of antiseptics, like triclosan and triclocarban, in health care practices has also been identified 
as a cause for concern by the FDA. Research suggested that higher levels of absorption and systemic 
exposure of antiseptic agents than what was previously believed
41
 takes place. In a study regarding 181 
pregnant women, triclosan was found in the urine of all women and was found in about half of the tested 
cord blood samples, indicating systemic exposure to triclosan. Researchers also found butyl paraben, another 
type of antiseptic commonly used in health care, in urine and cord blood
41
. Interestingly, a follow-up study 
found that the presence of some antimicrobial agents in maternal urinary and cord blood were associated 
with birth outcomes like lower gestational age at birth and birth weight as well as length.  The possible 
disruption to foetal development and hormone function by triclosan and other antimicrobial compounds, is 
thus concerning in terms of the long term effects of these agents in health care workers who are pregnant or 
breastfeeding as the effects of frequent use are unclear
41
.   
Waterless hand sanitizers usually contain isopropanol, ethanol or benzalkonium chloride as the active 
ingredient
41
. Studies have shown that high levels of skin absorption and systemic exposure of these agents 
takes place as waterless hand sanitizers are frequently used and not washed off (actually they are only 
effective when left on the skin). Medical personnel are required to use hand sanitizers before and after 
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contact with patients and always after removing examination gloves. They therefore use waterless hand 
sanitizers more often than prescribed and this may increase their exposure to potentially harmful 
ingredients
41
. As the use of hand sanitizers form an integral part in effective infection prevention, this could 
result in medical personnel applying a sanitizing product up to 100 times per day, which well exceeds the 
normal day to day use.  
2.4. Antimicrobial polymeric materials 
Microbial contamination is of great concern in numerous areas, including medical devices, healthcare 
products, food packaging, food storage and household sanitation
42
.  Bacterial contamination which may lead 
to serious implant-associated infections
42
 is of great concern in medical disciplines that utilise biomaterials, 
like for catheters and implants. Controlling microbial growth is thus one of the fundamental survival 
techniques for all higher species. A great variety of defence mechanisms against microbes have been 
developed in nature itself by plants, animals and even microbes. These mechanisms however often do not 
function efficiently in human society, meaning that microbial infections are high in the list of “killers”. 
Resistant microbial strains further hinder treatment, as well as the number of antibiotic-immune patients 
increasing faster than the development of useable antibiotics
43
.  
Antimicrobial polymers as an alternative to existing biocides are of great importance. Although the working 
mechanism of a large number of structurally different polymers is not fully understood, some of them are 
known for their low potential of developing resistant microbial strains
43
.  
Microbial cells have the ability to attach to artificial surfaces in a moist environment and can thus survive 
and proliferate as artificial materials commonly lack a defence mechanism against microbial growth
42
. As the 
number of cells increases on the surface the cells start to form a biofilm of a polysaccharide matrix 
containing embedded cells
43
. These biofilms allow microbes to survive under harsh environmental conditions 
and make the cells up to 1000 times less susceptible to most antibiotics and biocides
43
. The toxins excreted 
from these biofilms make them pathogenic
43
. Antibiotic genes may also be spread within the biofilm, 
increasing the formation of multi-resistant bacterial strains
43
. Man-made materials can also be degraded by 
microbial biofilms, necessitating the control of microbial growth on surfaces. 
The ideal antimicrobial polymer should
42
: 
a) be easy and inexpensive to synthesise 
b) be stable in long-term usage and storage at the temperature of its intended use 
c) be insoluble in water for a water-disinfection application 
d) not decompose to and/or emit toxic products 
e) not be toxic or irritating to those handling it 
f) have the possibility tobe regenerated upon loss of activity 
g) be biocidal to a broad spectrum of pathogenic microorganisms in brief times of contact. 
A possible way to address the problem of microbial surface contamination is to keep the environment 
sterile
42
 by using disinfectants like hypochlorite, hydrogen peroxide and other reactive oxygen species, silver 
salts, quaternary ammonium compounds, alcohols or the commonly used triclosan
43, 44
. The problem with 
this method is that the sterile state does not last long and frequent use of disinfectants poses great 
environmental problems as the use of disinfectants have shown to support the formation of microbial 
resistance, e.g. MRSA which causes more deaths than HIV in the USA
43
. 
Another way to combat microbial surface contamination is to prepare antimicrobial surfaces that prevent 
growth of biofilms
43
 as an alternative way to inhibit the spread of microbial infections. These surfaces can 
either repel microbes, meaning they cannot attach to the surface or they can kill microbes in the vicinity. To 
kill microbes in the vicinity the surfaces may be loaded with biocides like silver, antimicrobial ammonium 
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compounds, antibiotics, active chlorine or triclosan
43
. Although efficient, they eventually exhaust and the 
released biocides cause great environmental problems as microbial resistance may take place.  
Alternatively surfaces that can produce biocides catalytically by means of an externally applied chemical, 
electrical or optical energy, is an interesting option
43
. Also the design of surfaces that kill microbes on 
contact is a possible alternative. These surfaces in principle do not release biocides or exhaust and can be 
realised by tethering antimicrobial polymers.  
Literature reveals three general types of antimicrobial polymers: polymeric biocides, biocidal polymers and 
biocide-releasing polymers
42
. The general working of these are depicted below in Figure 2.5. 
 
Figure 2.5: General working principles of antimicrobial polymers: (a) polymeric biocides; (b) biocidal 
polymers; (c) biocide-releasing polymers
42
  
Polymeric biocides are based on the concept that the biocidal groups that are attached to the polymer act in a 
similar way as the analogous low molecular weight compounds; that means the repeating unit is a biocide
43
. 
Due to sterical hindrance caused by the polymeric backbone, one expects polymeric biocides to be less active 
than their low molecular weight counterpart. Polymeric biocides are thus polymers of bioactive repeating 
units, i.e.  polymers of interconnected biocides which act similarly to the monomers. The insoluble nature of 
the majority of polymers in water means that the polymerisation of biocidal monomers often does not lead to 
the formation of active antimicrobial polymers or polymerisation of a biocide leads to inability to reach the 
target by the biocidal functional group. 
 In biocidal polymers the entire macromolecule embodies the working of the antimicrobial agent, not 
necessarily requiring antimicrobial repeating units. Since the surface of microbial cells generally carry a net 
negative charge
43, 44
 due to their membrane proteins, polycations are attracted to the surface and if they have 
a proportionate amphiphillic character they have the ability to disrupt the outer membrane as well as the 
cytoplasmic membrane and can cause lysis of the bacterial cells
42
. To date this has been the established mode 
of action of polycationic antimicrobial polymers, like polycationic polymers containing quaternary 
ammonium and phosphonium, tertiary sulfonium and guanidinium functions
43
. 
Biocide-releasing macromolecules were first prepared by Vogl and Tirell who were able to polymerise 
salicylic acid that unfortunately did not result in polymers with antimicrobial properties. They were however 
able to demonstrate that the degradation of the polyester brought about the release of salicylic acid in a 
controlled fashion
43
. Biocide-releasing polymers do not actually act through the polymer itself, but instead 
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act as a carrier for biocides that can be transferred to the microbial cells for attack. These polymeric systems 
are usually the most active systems of these described, since they have the ability to release the carried 
biocides close to the cell in high local concentrations.  
Antimicrobial surfaces can also be produced by attaching antimicrobial polymers to different surfaces
43
 
through multiple techniques including chemical grafting, layer-by-layer deposition and plasma 
polymerisation
43
. At first, elaborate techniques were employed to covalently attach antimicrobial polymers to 
surfaces, like glass. An example of this is surface-grafted poly-4-vinyl-N-hexylpyridinium followed by 
modification of a glass slide with aminosilane and acryloyl chloride. The acrylated slide was then 
copolymerised with 4-vinylpyridine and finally alkylated with hexylbromide. This procedure is rather 
elaborate, requiring many chemical steps and the use of organic solvents
43
. This technique may be useful for 
laboratory preparation, but will not be feasible for industrial application. Quaternary ammonium compounds 
have also been successfully attached to porous glass beads by using 3-chloropropyltrimethoxysilane as 
coupling agent
45
. The glass beads were covered with the alkoxysilane followed by quarternisation of the 
immobilised chloropropyl residues with various N,N-dimethylalkylamines with alkyl groups between C2 and 
C18. The antibacterial behaviour of the glass beads were determined by passing bacterial cell suspensions 
through a column packed with the surface treated glass beads. Unquaternised surfaces did not show much 
antibacterial behaviour, whilst the surface treated glass beads functionalised with alkyl groups greater than 
C8 showed more substantial antibacterial activity as compared to the antibacterial behaviour of those with 
shorter alkyl groups.  
Surface-attached non-releasing polymers could be made by the incorporation of polymeric additives for 
polyurethane and acrylate coatings that migrate to the surface of the coating during the preparation of the 
coating
43
. The first approach utilises soft blocks of 1,3-propylene oxide with alkylammonium groups as 
crosslinked soft segments, whilst the second approach uses macromonomers based on polyoxazolines with 
biocidal quaternary ammonium end groups, copolymerised with the acrylate monomers and crosslinking 
agents.  
Another useful approach in the development of antimicrobial surfaces is utilising controlled radical 
polymerisation techniques to attach organic molecules capable of initiating polymerisation from the surface 
of the material. One example is the work done by Lee et al
46
 where they prepared non-leaching antibacterial 
glass and paper surfaces by means of controlled radical polymerisation. The surface was modified by the 
polymerisation of the tertiary amine-containing monomer 2-(N,N-dimethylamino)ethyl methacrylate 
(DMAEMA) in a “grafting from” fashion by means of atom transfer radical polymerisation (ATRP). The 
antimicrobial character on the polymer-modified surfaces is then achieved by quarternisation of the amino 
groups of PDMAEMA brushes with an alkyl halide.  
It also logically follows that one would try to polymerise a known antimicrobial agent that can be chemically 
modified into a derivative that may undergo polymerisation and retain its bioactive functional groups. 
Another possibility is the modification of the polymer backbone or its functional pendant groups (like 
hydroxyl, carboxyl or amino groups) by reaction with a complementary reactive antimicrobial agent. 
Benzalkonium chloride derivatives show a broad spectrum of antimicrobial activity. Styrene derivatives are 
ideal to create polycationic molecules that will retain the cationic character obtained from the quarternised 
group of the benzalkonium chloride derivatives. Another polymeric candidate is polymers containing 
biguanidines, like polyhexamethylene biguanidine, used as antimicrobial agent in contact lens disinfectant
47
.  
Many other antimicrobial polymers have been synthesised and evaluated for antimicrobial behaviour. Some 
of these include cationic polymers containing biguanide, phosphonium salts, quaternary pyridinium salts and 
quaternary ammonium salts as active functional groups
48
.  
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The ever increasing development of microbial resistance against common antimicrobial agents in use today 
necessitates the development of alternatives to known antimicrobial drugs and techniques used in the 
treatment of patients as well as techniques utilised in medical practice for safe and sterile equipment, devices 
and medical procedures. Incorporating known antimicrobial materials in different forms, like the 
nanoparticle encapsulated Amphotericin B, is a rather interesting development into new or better wound 
dressings that address problems like the associated nephrotoxicity of Amphotericin B. Development of 
antimicrobial polymers also prove to be a widely applicable technique for the introduction of new 
antimicrobial agents as well as products stemming from the polymer. The advantage of developing 
antimicrobial polymers stems from the ability to tailor polymers for a specific end purpose and utilising them 
in different physical forms, like films, fibres, coatings and emulsions.  
The ability to tailor polymers for a specific end purpose allows one to better obtain the conditions described 
for an ideal wound dressing. The discovery that moist wound environments improve healing also steers the 
development of modern wound dressings into the development of products like hydrogels. The necessary 
antimicrobial character needed to address infection may therefore be achieved by using an antimicrobial 
polymer or incorporating known antimicrobial agents into the favoured modern dressing (like a hydrogel). 
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Chapter 3: Synthesis, characterisation and modification of SMA 
3.1. Introduction 
Post-polymerisation modification of polymers to produce polymers with specific properties for a specific 
application is of common practice in recent years. In this study, the alternating polymer poly(styrene-alt-
maleic anhydride) (SMA) is selected as base polymer that will be modified after polymerisation and later 
used to produce nanofibres of SMA as well as nanofibres of the modified SMA polymer via the single needle 
electrospinning process. SMA is a cheap, readily available, easily synthesised and thermoplastic polymer
1
. 
Chemical modification of SMA can be easily achieved as the maleic anhydride units present in SMA are 
easily accessible and rather reactive, allowing for relatively easy modification of the SMA polymer. 
Modification of a polymer before the electrospinning process favours the formation of covalent bonds 
between SMA and the modifying agent. A modifying agent containing a reactive group that will covalently 
attach to SMA via a ring-opening reaction of the maleic anhydride unit will thus be a good agent for the 
modification process. The maleic anhydride residues show reactivity towards water, alcohols and primary as 
well as secondary amines. One can thus synthesise nanofibers with tailored functionalities by simply 
selecting modifying agents containing amine or alcohol moieties in the modification process of SMA. 
Amines however exhibit a greater nucleophilic character as opposed to alcohols and are the agent of choice 
as the ring-opening reaction at the anhydride moiety requires strong nucleophilic anhydride-reactive agents.  
The modification agents used in this case are selected in order to obtain a functionalised polymer that 
exhibits antimicrobial characteristics. A primary amine functional group from the modifying agent is 
available for the nucleophilic reaction with the reactive anhydride group. The anhydride group undergoes a 
ring-opening reaction within the five membered maleic anhydride moiety to yield an amide. Heat treatment 
is then used to obtain a stable five membered cyclic imide. Functional groups can also be introduced to the 
pending side chain of the imide simply by choice of the primary amine reacted with the maleic anhydride 
residues. If the functionality in the pending side chain contains a tertiary amine, it can be subjected to further 
reaction with an alkyl halide to yield a quaternised SMI (qSMI) polymer that contains a positively charged 
aliphatic quaternary ammonium group. 
3.2. Results and discussion 
This chapter describes the procedures and protocols used in the synthesis and characterisation of the 
alternating polymer poly(styrene-alt-maleic anhydride) (SMA). Furthermore, post-polymerisation 
modification of SMA with a primary amine to form poly(styrene-alt-(N-substituted-maleimide)) (SMI) and 
its derivatives is also described. The polymers synthesised and modified during the study were then used in 
the electrospinning process described in Chapter 4 to produce functionalised polymer nanofibers.  
3.2.1. Synthesis of poly(styrene-alt-maleic anhydride) copolymer 
An alternating copolymer of styrene and maleic anhydride (MAnh) was synthesised in a 1:1 molar ratio of 
styrene:maleic anhydride, using conventional free radical chemistry. The initiator was added in a 200:1 
monomer:initiator ratio. The procedure was followed as described in the work done by Cloete et al
2
.  
In a 1000 mL round bottom flask equipped with a stirrer bar, styrene (30 g, 0.288 mol) was dissolved in 400 
mL MEK, along with maleic anhydride (28.25 g, 0.288 mol) and AIBN (0.2365 g, 0.00144 mol). The 
reaction mixture was degassed with N2 for at least 30 min and then reacted overnight under reflux at 60 °C. 
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The polymer was precipitated in isopropanol and dried under vacuum at 60 °C overnight to remove residual 
solvent and unreacted monomer. 
 
Scheme 3.1: Reaction scheme of the synthesis of poly(styrene-alt-maleic anhydride) via conventional 
free radical polymerisation. 
Scheme 3.1 represents the schematic illustration of the reaction between the monomers to yield SMA (yield= 
93.27 % [54.33 g], Mn= 222 856 g·mol
-1
, Ð= 2.01).  Molar mass (Mn) and dispersity (Ð) were determined by 
means of size exclusion chromatography (SEC) in a N,N-dimethylacetamide system (DMAc), calibrated with 
PMMA standards. Free radical polymerisation typically yields polymers with relatively high Ð values and is 
reflected in the Ð value of 2.01 obtained.  
1
H-NMR (DMSO-d6): δ (ppm) = 6.6-7.5 (s broad, 5H aromatic), 3.2-3.5 (s broad, 2H, -CH-CH-), 1.8-2.2 (s 
broad, 3H, -CH-CH2-). 
 
Figure 3.1: ATR-FTIR spectrum of SMA 
In Figure 3.1 the characteristic carbonyl symmetric and asymmetric stretching vibrations of the maleic 
anhydride moiety can be seen at 1810 and 1750 cm
-1
. The signals observed at 1605 cm
-1
 and 1500 cm
-1
 are 
due to the C=C stretching of the aromatic styrene ring and the C-H bending vibration of the aromatic ring. 




 and 920 cm
-1
 are assigned to the cyclic anhydride groups.  
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3.2.2. Modification of SMA with 3-(N,N-dimethylamino)propyl-1-amine to yield poly(styrene-alt-N-(3-
(N’,N’-dimethylamino)propyl)maleimide) (SMI) 
Modification of the SMA polymer described in Section 3.2.1 took place at the cyclic anhydride moiety of the 
copolymer via a nucleophilic addition reaction using 3-(N,N-dimethylamino)propyl-1-amine (DMAPA), an 
N-alkylamine, containing a primary as well as a tertiary amine group. The reaction between the anhydride 
residues and a primary amine is rapid and straight forward. The addition reaction results in a ring-opened 
structure that contains a carboxylic acid and an amide group.  The polymer underwent heat treatment and 
loss of water at the amide to yield a cyclic maleimide product. The modification reaction is shown below in 
Scheme 3.2.  
 
Scheme 3.2: SMA modification with primary amine and subsequent loss of water to yield SMI 
Scheme 3.3 indicates the modification of SMA with DMAPA. In a 100 mL three-neck round bottom flask 
equipped with a magnetic stirrer bar, SMA (1.000 g, 0.004945 mol) (calculated MAnh fraction) was 
dissolved in 20 mL N, N-dimethylformamide (DMF). DMAPA (see Table 3.1 for amount of DMAPA used 
in each modification) in 10 mL DMF was added dropwise to the SMA over a period of 30 min. The white/ 
yellowish reaction mixture was left to stir for a further 2 hrs at room temperature, then gradually heated to 
160 °C and left under reflux for 4-6 hrs
3
 to yield the clear yellow ring closed maleimide product. The 
resulting polymer was precipitated in cold diethyl ether, isolated and dried under vacuum overnight. In the 




Scheme 3.3: Reaction scheme of SMA modification with DMAPA 
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Table 3.1: Modification of SMA with DMAPA 
% Modification DMAPA (g) mmol Yield (g) 
30 0.1516 1.484 1.027 
40 0.2021 1.978 1.068 
50 0.2527 2.473 1.121 
60 0.3032 2.967 1.113 
70 0.3537 3.462 1.143 
80 0.4043 3.956 1.203 
90 0.4548 4.451 1.319 
 
Figure 3.2: Stacked ATR-FTIR spectra of SMA and SMI 
The imidisation of the SMA can be confirmed from the shift of the C=O carbonyl anhydride peaks to a lower 
wavenumber as indicated by the blue and red lines in Figure 3.2. These peaks are characteristic of the 
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symmetric and asymmetric stretch vibrations of the C=O bond within the imide groups. The presence of the 




Figure 3.3: Stacked ATR-FTIR spectra of partially imidised SMI 
In Figure 3.3, like in Figure 3.2, we also notice a shift in the C=O peaks of the carbonyl anhydride units to a 
lower wavenumber as indicated by the blue and red lines. The intensity of the C=O peaks of the imide 
functionality seems to increase as the percentage of imidisation also increases. An increase in intensity of the 
tertiary amine signal, indicated by the magenta box, can also be observed. 
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During the partial modification of SMA with DMAPA as described above and indicated in Table 3.1, the 
formation of a white solid was observed. For modifications below 70 % (i.e. 30-60 %) it was observed that 
aggregation or clumping takes place after 30 min of DMAPA addition. The aggregated solid was still present 
after heating to 160 °C and stirring for 6 hrs. A colour change from white to yellow of the aggregate was also 
observed. Modifications above 70 % did not show any clumping or aggregation after 30 min of DMAPA 
addition. After heating to 160 °C for 6 hrs, the white solid observed at the point where DMAPA dripped into 
the SMA solution, was no longer present and colour change from white to clear yellow was observed. This 
was interesting as the crosslinking process of the SMI polymers could not be completely described as of yet.   
3.2.2.1. Model study 
A model study (Scheme 3.4) using a compound similar to the maleic anhydride unit was devised in order to 
try and explain this clumping phenomenon observed. The observed clumping may possibly be related to the 
crosslinking of SMI and its derivatives, like in the case of quaternised SMI (qSMI) fibres after they have 
been subjected to heat treatment. Heat treatment of qSMI fibres at 120 °C renders the fibres insoluble in 
water and organic solvents.  The following model study may then be able to explain the clumping as well as 
shed some light on the crosslinking of qSMI fibres. 
 
Scheme 3.4: Schematic representation of model study 
The model compound used in this study was chosen to be 1,2-cis-cyclohexanedicarboxylic anhydride as it is 
similar to maleic anhydride and the most reactive site of the compound is the anhydride moiety. The model 
compound was reacted in a 1:1 ratio with DMAPA and characterised. 
In a 50 mL round bottomed flask equipped with a stirrer bar 1,2-cis-cyclohexanedicarboxylic anhydride 
(2.000 g, 0.01297 mol) and DMAPA (1.326 g, 0.01297 mol) in 10 mL dry THF were added. The reaction 
was left to stir at room temperature overnight in order to ensure completion of the reaction. Upon completion 
of the reaction, a white solid was observed. The solvent was removed and the product heated to 100 °C under 
vacuum overnight to yield the ring closed product. The product (3.019 g) was analysed using NMR and 
ATR-FTIR. 
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Figure 3.4: Stacked 
1
H-NMR spectra of the model compound, DMAPA and the ring closed product 
1
H-NMR of the starting materials could be successfully assigned as seen in Figure 3.4. The 
1
H-NMR of the 
product could also be successfully assigned. The shift in ppm of peaks g, h and j to chemical shifts downfield 
in the product also confirms the success of the synthesised product. For protons c and f we notice one peak 
present in the 
1
H-NMR of the product. This is due to the second peak overlapping with the peak observed for 
the protons labelled h. The large shift in ppm of g may be ascribed to the de-shielding effect caused by the 
presence if the imide moiety.  
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Figure 3.5: ATR-FTIR spectra of model compound, DMAPA, ring opened product and ring closed 
product 
From the ATR-FTIR spectra in Figure 3.5 we notice that the C=O stretch observed at 1810 and 1780 cm
-1
 in 
the model compound shifted to 1780 and 1690 cm
-1 
in the product. This is characteristic of the formation of 
the imide bond observed in the product. We also notice the disappearance of the broad OH-stretch from the 
ring opened product at 3600-3050 cm
-1
 in the ring closed product. 
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Literature also revealed that it is possible for maleic anhydride to sometime react with tertiary amines
4, 5
. 
Depending on their overall structure, tertiary amines have the ability to undergo a variety of reactions. In 
1942, Van Alphen
4
 studied the reaction of triethylamine (TEA) with maleic anhydride (Scheme 3.5). He 
isolated a black impure substance that was water soluble and released TEA upon reaction with a base. 
Another group observed that above mentioned reaction was exothermic and initially noticed a clear yellow 
solution, but later isolated a dark brown solid. They rationalised their observations by stating that a charge-
transfer complex (or π-complex) forms upon mixing the reagents, forming the yellow solution. The π-
complex forms an intermediate σ-complex before collapsing to form the dark brown product. This is 
represented graphically in Scheme 3.5. 
 
 
Scheme 3.5: Reaction of maleic anhydride with triethylamine forming suggested π- and σ-complexes 
The model compound was then also reacted with TEA in order to confirm the possibility of an 
intramolecular reaction that may further explain the clumping observed or even crosslinking of qSMI fibres.  
 
Scheme 3.6: Reaction of model compound with TEA 
In a 50 mL round bottomed flask equipped with a magnetic stirrer bar, the model compound and TEA were 
reacted in a 1:1 ratio. TEA (1.313 g, 0.01297 mol) in 10 mL THF was added to the model compound (2.000 
g, 0.01297 mol). The reaction was left to stir at room temperature overnight in order to ensure completion of 
the reaction. The solvent was removed and the amber coloured product (2.894 g) was dried under vacuum 
overnight as well. The product was then subjected to NMR and ATR-FTIR analyses. 
π-complex σ-complex 
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Figure 3.6: Stacked 
1
H-NMR spectra of the model compound, TEA and their product 
In Figure 3.6 the 
1
H-NMR of the product revealed a shift in ppm to a more downfield value from the starting 
materials. All signals could be accounted for, thus confirming the successful reaction of the starting materials 
to yield the product. 
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Figure 3.7: ATR-FTIR spectra of the model compound, TEA and the product of their reaction 





. We also notice a change in the tertiary amine C-N stretching region indicated by the blue dashed 
box. This thus confirms that the reaction was successful. 
1, 2-cyclohexandedicarboxylic anhydride 
TEA 
Product 
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3.2.3. Synthesis of functionalised SMI polymers 
The work done by Bshena and co-workers
6
 in 2008 utilised different alkylhalides as quaternisation agents in 
the modification of SMI, namely 1-bromobutane, 1-bromooctane and 1-bromododecane.  Bshena found that 
aliphatic chains with more carbon atoms showed promising results towards antimicrobial efficiency. For this 
reason 1-bromooctane and 1-bromododecane were selected as modifying agents to compare.  
SMI-qC8 and SMI-qC12 were prepared by an addition substitution reaction of the SMI precursor with the 
above mentioned bromoalkanes. Scheme 3.5 illustrates the modification from SMA to the quaternised 
product.  
  
Scheme 3.7: Reaction scheme of modification of SMA to yield the SMI precursor and subsequent 
modification with alkyl halides to yield quaternised SMI 
The modification procedures for both bromooctane and bromododecane are identical. The reaction procedure 
for bromooctane is described below. 
In a round-bottomed flask with a condenser and magnetic stirrer bar, SMI (3.000 g, 10.4 mmol equivalents of 
MAnh) was dissolved in 100 mL DMF. Then 1-bromooctane (2.512 g, 13.01 mmol) was added dropwise and 
the reaction mixture stirred at 100 °C. The reaction was stopped after 30 hours. To ensure complete 
modification, 1-bromooctane was added in molar excess of 1.25 times relative to the maleimide moieties. 
Successful synthesis was confirmed by ATR-FTIR. 
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Figure 3.8: ATR-FTIR spectrum of SMI qC8 
From Figure 3.8 we notice the increase in the intensity of the C-H stretching of the –CH3 and –CH2 groups at 
2850 and 2800 cm
-1
. We also notice a broad band centered around 3400 cm
-1
.The peaks observed due to C-H 
stretching as well as the appearance of the broad band attributed to the ammonium cation confirm the 
successful quaternistion of the tertiary amino groups of the SMI precursor. 
Stellenbosch University  https://scholar.sun.ac.za




Figure 3.9:  Stacked ATR-FTIR spectra of SMA, SMI and SMI-qC8 
Like previously discussed, in Figure 3.9 we see the shift in wavenumbers of the C=O stretch due to 
imidisation as indicated by the blue and red lines, as well as the change in the tertiary amine region as 
indicated by the magenta box. This confirmed the successful synthesis to yield the quaternary ammonium 
product. 
3.3. Conclusion 
The conventional free radical synthesis of SMA was successful as could be confirmed using NMR and ATR-
FTIR. SEC analysis showed that a polymer with a number average molar mass (Mn) of 222 856 g.mol
-1
 and 
dispersity (Ð) of 2.01 was obtained. The subsequent modification of the SMA to yield the quaternised 
polymers SMI-qC8 and SMI-qC12 via an SMI intermediate could also be successfully confirmed by means of 
ATR-FTIR analysis. These polymers can thus be used for the electrospinning process described in Chapter 4.  
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A model study where the model compound, namely 1,2-cis-cyclohexanedicarboxylic anhydride, was reacted 
with DMAPA, (a compound containing both a primary and tertiary amine) and a tertiary amine (TEA) was 
developed as seen in Scheme 3.4 and Scheme 3.6. The model compound was successfully reacted with both 
compounds. The successful reaction of the model compound with TEA suggests that at lower modifications 
of SMA with DMAPA (30-60 %) intramolecular crosslinking reactions takes place with the tertiary amine 
group of DMAPA since the primary amine readily reacts with the anhydride moiety of SMA. This may also 
be a plausible explanation for the crosslinking process observed in quaternised SMI fibres when these fibres 
are subjected to heat treatment in vacuo, rendering these fibres insoluble in water and organic solvents. 
3.4. Experimental 
3.4.1. Experimental and characterisation details 
The following chemicals and solvents were commercially obtained and used as received, without further 
purification, unless stated otherwise. Maleic anhydride 99% (Sigma-Aldrich), 3-(N,N-dimethylamino) 
propyl-1-amine 99% (Sigma-Aldrich), 1-bromooctane 98% (Sigma-Aldrich), 1-bromododecane 98% 
(Sigma-Aldrich), 1,2-cis-cyclohexanedicarboxylic anhydride  95% (Sigma-Aldrich), triethylamine 99% 
(Sigma-Aldrich), methyl ethyl ketone ≥99.7% (Sigma-Aldrich), isopropanol (Kimix), diethyl ether (Kimix), 
N,N-dimethylformamide (Kimix), deuterated dimethyl sulfoxide (Sigma-Aldrich, 99.9 atom % DMSO-d6) 
and deuterated acetone (Sigma-Aldrich, 99.9 atom % Acetone-d6) were used as received from the suppliers. 
Styrene monomer 99.5% (Fluka Chemicals) was purified by means of an aluminium oxide column and 2, 2ᶦ -
azo-bis (isobutyronitrile) (AIBN) (Riedel de Haen) was recrystallized from methanol and dried under 
vacuum before use.  
3.4.1.1. Nuclear Magnetic Resonance (NMR) 
The NMR analyses were done using Varian Inova 300 MHz, 400 MHz and 600 MHz NMR spectrometers. 
The interpretation of the obtained spectra was done using MestReNova (Version 6.0.2-5475) computer 
software. Sample preparations were done in deuterated DMSO and deuterated acetone. 
3.4.1.2. Attenuated total reflectance Fourier Transform Infrared (ATR-FTIR) spectroscopy 
A Nicolet FTIR (Nexus model) FTIR spectrometer from Thermo-Fischer was used to record infrared spectra. 
The FTIR was equipped with a Smart Golden Gate ATR accessory and a diamond/ZnSe internal reflection 
crystal. All samples are solids and did not require any sample preparation. The spectrum of each sample was 




 with a spectral resolution of 8 cm
-1
 and 64 scans per run. Data 
acquisition was done using Omnic software and Origin software used for data processing.  
3.4.1.3. Size Exclusion Chromatography (SEC) 
Size exclusion chromatography (SEC) was used in order to determine molar mass and dispersity (Ð). The 
SEC analysis was done on a dimethyl acetamide (DMAc) system consisting of a Shimadzu LC-10AD pump, 
a Waters in-line degasser AF and a Waters 717plus autosampler. A Waters 2487 dual wavelength UV and a 
Waters 410 differential refractive index (DRI) is connected in series as detection systems. Dimethyl 
acetamide (DMAc, HPLC grade, stabilized with 0.05% BHT and 0.03% LiCl) is used as eluent at 40 °C and 
a flow rate of 1 mL/min. The system is calibrated using narrow poly(methyl methacrylate) (PMMA) 
standards ranging from 634 to 1.94410
6
 g/mol. The column set include a 50  8 mm guard column in series 
with three 300  8 mm, 10 μm particle size GRAM columns (two 3000 Å and a 100 Å) obtained from 
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Polymer Standards Service (PSS). Sample preparation entailed dissolving the polymer in BHT/LiCl 
stabilised DMAc to a maximum concentration of 2 mg/ mL and filtering before subjecting to analysis. 
3.5. References 
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Chapter 4: Electrospinning and hydrogel formation 
4.  Abstract 
This chapter describes the electrospinning process in detail as well as the application of the single needle 
electrospinning technique to create non-woven nanofibrous mats from SMA, sodium alginate and the 
quaternised SMI polymers described in Chapter 3.  
4.1. Electrospinning 
The electrospinning technique has been known for almost a century
1
. The principle is based on a polymer 
solution or polymer melt being spun into fibres by electrostatic forces
1
. The electrospinning process has 
gained a lot of attention due to growing interest in nanotechnology and its applications
2-6
. The process is 
versatile in terms of creating a wide variety of fibres and also allows the fabrication of continuous polymer 
nanofibres in the submicron and nanometre range (between 50-500 nm in diameter)
7
. The electrospinning 
technique can also produce thin fibres with a variety of cross-sectional shapes, like branched fibres, flat 
ribbons and ribbons with other shapes
8
. 
Electrospinning is an ever evolving simple, cost effective and promising technique which facilitates the 
production of multi-functional nanofibres from numerous polymers, polymer blends, polymer composites 
and ceramics
9, 10
. Modification of polymer nanofibres through electrospinning is of great interest due to the 
unique properties obtained from the process when fibre diameter is decreased from micrometres to 
nanometres. The smaller fibre diameter leads to properties like smaller pore size, high surface area, 
flexibility in surface functionality, high specific surface area to volume ratio, uniform fibres, porosity, 
increased mechanical strength and high aspect ratios
2,11-13
. The aforementioned properties make for attractive 
options for numerous applications of polymer nanofibres, including food packaging, nanocatalysts, tissue 
scaffolds, protective clothing and textiles, filtration media, nanofibrous structures, storage cells for hydrogen 
fuel cells, optical electronics, reinforcements of nano-composites and drug delivery
2, 14
.  
Another favourable attraction of the electrospinning technique is the feasibility to modify not only the 
morphology of the nanofibres and internal bulk content, but also their surface structure. Post-spinning 
modification by chemical or physical vapour deposition is also possible. Another interesting modification 
can be made by controlling secondary structures of the nanofibres in order to obtain nanofibres with core or 
sheath structures, hollow interiors or a porous structure
15
. 
4.1.1. The single needle electrospinning process 
In the single needle electrospinning process, a single blunted needle is attached to a syringe filled with a 
polymer solution or polymer melt. A high voltage supply is attached to the needle tip. By attaching the 
positive end of the high voltage power supply to the needle tip, it may act as a positive electrode. At a 
distance set by the user; a collector plate that is covered in aluminium is placed and acts as the negative 
electrode when the negative end of the same high voltage power supply is attached to the collector plate. A 
syringe pump regulates the flow rate of the polymer solution, pushing a droplet of the polymer solution 
through the needle tip. Two opposing forces now act on the droplet: the first the contractive surface tension 
of the polymer solution and the second is the same charge electrostatic repulsive forces that are introduced 
by the high voltage power supply
14
.  Similar charges are induced in the polymer solution by means of the 
attached electrode. These charges now flow through the solution, accumulating on the surface of the solution 
droplet released at the needle tip and increase the charge density at the surface. Electrostatic repulsion takes 
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place, the force promoting the expansion of the surface area of the droplet, whilst the force from the surface 
tension will promote a reduction in the surface area of the droplet.  
 
Figure 4.1: Illustration of variations in the single needle electrospinning process
16
  
In Figure 4.1 in the middle we see the typical electrospinning setup. Top left shows a schematic of a co-axial 
spinneret with accompanying SEM images of the corresponding hollow nanofibres. In the top right corner 
the electrospinning of a polymer solution containing polymer particles is shown along with a fluorescence 
image that shows encapsulation of the polymer particles in the fibres. The image in the bottom left corner 
shows electrospinning with duel spinnerets and an accompanying fluorescence image showing a non-woven 
mat containing two different types of polymeric nanofibres. Lastly in the bottom right corner electrospinning 
with a hemispherical bowl collector and a confocal fluorescence image that illustrates the typical cotton-ball 
like scaffold of fibres. 
As the electric field is increased, a critical value is reached where the electrostatic repulsive force overcomes 
the surface tension and a charged polymer jet is ejected from the tip of the Taylor cone
2
. A stable and straight 
jet is present right after ejection of the jet. The region of bending instability is reached after the jet passes this 
stable and straight segment
17, 18
. The charged jet is repelled from itself and undergoes whipping, due to the 
same charge of the ions contained in the polymer jet. The charged jet coils onto itself with each coil growing 
in radius. Secondary bending takes place as the charge repulsion along the fibre increases. This whipping 
action eventually stretches and elongates the charged jet, decreasing fibre diameter to produce fibres on 
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. During this process the solvent evaporates, solidifying the fibres and dry fibres 
accumulate on the collector plate.  
Figure 4.1 shows a few ways how the electrospinning technique can be varied to produce different kinds of 
fibres. The ease of which one can produce nanofibres using single needle electrospinning is a desirable 
advantage of the electrospinning technique. Unfortunately single needle electrospinning does not yield large 
quantities of fibres, complicating production on a larger scale.
21
. This means that on an industrial scale as it 
has a slow production rate, making it economically unsustainable and unsuitable for industrial application. 
Due to the unsuitability for industrial application, research into upscaling the production process has been 
done and ball electrospinning was developed in order to increase production rate. 
4.1.2. Parameters affecting the electrospinning process 
A number of parameters and processing variables that interact differently and simultaneously influence the 
electrospinning process
2,15,17,23
. They are: 
1. Electrospinning conditions described by the system or operational parameters, namely electric field 
strength, solution feed rate and distance between the capillary (needle or ball) and target (collector). 
2. Solution parameters such as shear and elongation viscosity, conductivity, surface tension, dielectric 
constant of the solution, molar mass and distribution of the polymer as well as the architecture of the 
polymer (whether the polymer is linear or branched). 
3. External parameters like environmental conditions of the electrospinning setup, including ambient 
temperature, the temperature of the solutions and the relative humidity. 
A change in one of the parameters may affect one or more of the other parameters. A good example of this 
effect can de described in terms of chain entanglement necessary for electrospinning. In order for fibres to 
form, an acceptable number of chain entanglements are necessary. Entanglements are dependent on the 
molar mass and/or the concentration of the polymer solution. The molar mass and concentration of the 
polymer should be sufficiently high for fibre formation; however it cannot be so high that the relevant 
viscosity of the solution prevents polymer jets being formed by the electric field. The electric field and the 
surface tension should be low enough for a polymer jet formation and ejection. The viscosity should also be 
of such a nature that it prevents the collapsing of the jet into droplets to form beads-on-a-string type fibres 
due to incomplete solvent evaporation
2, 24
. Almost any polymer can thus be electrospun by simply changing 
the electrospinning process conditions and solutions parameters listed above
25
.  
4.1.3. Electrospinning process parameters that affect fibre diameter 
Solvent evaporation and solidification of the polymer jets are important for the formation of nanofibres. The 
diameter of the fibres is primarily dependent on the size of the jets and the polymer solution itself
2
. Fibre 
diameter is greatly affected by the applied electric field strength, the distance between the capillary and 
target, and the flow rate. The solution parameters that affect fibre diameter are viscosity and solution 
conductivity
17,26
. The applied voltage and distance between the needle tip and collector plate determine the 
electric field exerted on and experienced by the polymer jet. The extent of whipping and elongation 
experienced by the polymer jet is mostly affected by the aforementioned parameters and thus has a direct 
influence on fibre diameter.  
4.1.3.1. Electric field 
An electric field, generated by a high voltage supply, is required between the needle tip of the syringe filled 
with the polymer solution and the collector plate in order for the electrospinning process to proceed. The 
electric field is thus a parameter that significantly affects fibre diameter. The electric field is a function of the 
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voltage applied as well as the distance from the needle tip to the collector. This relationship is defined by the 
following equation where E= electric field strength measured in kV/cm, V= Voltage difference between 





Equation 4.1: Electric field strength equation  
As mentioned before, a polymer jet is only ejected from the surface of the polymer droplet once the 
electrostatic forces overcome the surface tension of the solution
27
. The charged polymer jet then undergoes a 
process of whipping and elongation in the bending instability region as a result of electrostatic repulsion 
within the jet. It is during this process of whipping and elongation that the fibre diameter decreases until the 
solvent has evaporated and dry fibres collect on the collector plate
28
. If the applied electric field is increased, 
more charges will accumulate at the surface of the polymer droplet. The greater number of charges present 
on the surface of the droplet means that the newly ejected jet will be able to undergo more whipping and 
stretching, resulting in finer fibres
4, 29-31
. The higher the charge density carried by the jet surface, the less 
beading takes place
26
. Beading is greatly affected by the applied electrical field
32
. Increasing the 




4.1.3.2. Distance between the needle/ball and target 
The distance between the needle tip and the collector directly influences the electric field strength as seen in 
Equation 4.1. A greater distance between the needle/ball and the target results in smaller fibre diameters as 
the jet has more traveling time and undergoes whipping and stretching to a greater extent
4, 24, 33
. If a high 
electric field is applied but the distance to the collector is small, thicker fibres may form as a result of more 
fluid ejected in a jet and shorter travelling time. This means that the jet does not have sufficient time to whip 
and stretch
2
 and solvent evaporation does not take place efficiently, resulting in wet fibres or even a film on 
the collector plate. An effective spinning distance is thus important in order to allow for whipping and 
elongation to take place and to ensure the drying of fibres before they reach the collector plate. 
4.1.3.3. Flow rate of the solution 
The flow rate of the polymer solution through the needle is controlled by a syringe pump. Variation in the 
flow rate brings about variation in the fibre diameter
34
. Larger fibre diameter can be observed when a larger 
flow rate is maintained. This is due to the greater amount of the polymer solution that can be drawn from the 
needle tip
4, 34
. A too high flow rate results in dripping of the polymer solution from the needle tip. This 
means that the available charge cannot carry away the excess polymer solution fast enough
31
. In the case of a 
too low flow rate, the Taylor cone disappears as not enough solution is available for the deformation process, 
resulting in a discontinuous jet. An optimal flow rate is thus important in order to maintain a stable Taylor 
cone.  
4.1.3.4. Viscosity 
Viscosity, or the resistance of a solution to flow, is dependent on the molar mass and concentration of the 
polymer and is a primary parameter affecting fibre diameter
29
. An increase in the molar mass and 
concentration allows for more chain entanglements, and also increases the viscosity. In a solution where the 
viscosity is too low electrospraying will take place as too little chain entanglements are present to stabilise 
the jet. Instead the jet will break up into droplets
29
. On the other hand, a solution with too high viscosity will 
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also be difficult to electrospin as the jet will be difficult to induce. The greater viscosity means that more 
chain entanglements are present, hindering the flow of the solution as well as deformation in the Taylor cone 
region
2,26,31,33
. One can thus say that higher viscosity decreases the pathway of the jet and this means that less 
whipping and stretching will take place, resulting in larger fibre diameters.  
4.1.3.5.  Surface tension 
The surface tension parameter plays an integral role in the jet initiation and bending instability processes. In 
order for stable Taylor cone formation and subsequent jetting to take place, the electric field charge needs to 
be of such a nature that it can overcome the surface tension of the spinning solution, if not, the surface 
tension will be the dominant force and fibre formation may not occur
4
.  
4.1.3.6. Electrical conductivity 
The ability of a solution to transfer charges through its molecules, solvent molecules, additives or impurities 
within the solution defines its electrical conductivity. Once the polymer jet is ejected, whipping and 
stretching of the polymer jet is caused by the repulsion between charges of the same kind. The conductivity 
of a solution is thus important as the distribution of charges is necessary for the successful formation of the 
polymer jet and the whip and stretch process
29
. A higher electrical conductivity in a solution means that a 
larger number of charges may be distributed in the solution. This will result in the whipping and stretching 
process taking place to a greater extent and ultimately producing fibres with a smaller diameter. It also 
follows that a solution that does not exhibit electrical conductivity cannot be electrospun as the necessary 
charge transfer cannot take place among the molecules. The electrical conductivity of a solution can however 
be increased by adding a salt, increasing the temperature or using different solvents or solvent combinations 
in the solution. Full dissociation of the salt within the solvent means that both positively and negatively 
charged ions are present within the solution. The ions may move independently, each with the ability to 
partially carry the charge. The addition of a salt thus allows the solution to better carry the charges and in 
turn increases the electrical conductivity of the solution
2
. 
4.2. Electrospinning of SMA and subsequent hydrogel formation 
Electrospinning of SMA required the determination of the optimum conditions for the production of uniform 
nanofibres. The conditions that needed to be optimised include the voltage applied, the distance from the 
needle tip to the collector plate, feed rate of the polymer solution, the concentration of the solution and the 
solvent system used. The solvent system should first of all have the ability to properly dissolve the polymer. 
Secondly, other considerations taken into account when selecting a proper solvent system include toxicity 
and the dielectric constant of the solvents. Once the optimum conditions were determined, SMA could be 
electrospun in order to create a hydrogel. 
4.2.1. SMA crosslinked with different crosslinking agents 
 In a typical procedure for the preparation of water-absorbing SMA nanofibres, a solution containing 10 wt 
% SMA with diethylene glycol (DEG) as a crosslinker in a 10 % molar ratio to the SMA, was spun from a 
1:2 DMF/acetone solution. 
Table 4.1: Electrospinning conditions of SMA 
Collector distance (cm) Voltage (kV) Flowrate (mL/min) 
15 15 0.012 
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The resulting electrospun nanofibrous membrane was put in an oven at 100 °C for 2 h to allow for 
crosslinking of the fibres. Crosslinking was therefore done after electrospinning. The crosslinked SMA 
nanofibrous membrane was hydrolysed in a 1.5 M NaOH/ethanol solution for 24 h at room temperature. This 
was then followed by washing with ethanol and drying in vacuo at 50 °C for 10 h. The resultant nanofibrous 
mat was soft and pliable. Scheme 4.1 below represents a graphical representation of crosslinking with DEG. 
The primary alcohol group of DEG can react with the anhydride residue of SMA to produce the product 
represented in Scheme 4.1. Notice that the product has a primary alcohol available for reaction with another 
anhydride unit at the end of the glycol chain. 
 
Scheme 4.1: SMA crosslinked with DEG 
Using this technique to crosslink SMA also has its drawbacks as it is difficult to quantify the level of 
crosslinking that take place between the SMA fibres. Even though a 10 molar percentage of the crosslinker 
was added, one cannot definitively say that a 10 % crosslinking density exists within the fibre matrix. This is 
due to the possibility of the crosslinker evaporating with the solvent as well as incomplete or intermolecular 
reaction.  
Other crosslinking agents were also considered. SMA was also crosslinked with ethylene diamine (Scheme 
4.2). Using this crosslinker meant that the crosslinking procedure described above had to be modified, as 
addition of the crosslinker to the spinning solution increased the viscosity of the solution, making it difficult 
or even impossible to spin. This meant that crosslinking was already taking place before electrospinning was 
complete. This can be expected due to the rapid reaction that takes place between the anhydride moiety of 
SMA and a primary amine. In a typical procedure for the preparation of water-absorbing SMA nanofibres, a 
10 wt% SMA solution was prepared in a 1:2 DMF/acetone solution. After the completion of the spinning 
process, the obtained fibres were dipped into an isopropanol solution containing 10 molar percentage of the 
crosslinker to anhydride units. The fibre mats prepared in this manner shrunk and was very brittle upon 
drying, making it difficult to work with, in the context of a wound dressing.  
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Scheme 4.2: SMA crosslinked with ethylene diamine 
From the crosslinking agents already used, it seemed that another crosslinking agent that combined the 
properties of the other two crosslinking agents would be a good choice to achieve crosslinking that may be 
quantifiable. This crosslinker would therefore rapidly react with the anhydride units, like for the primary 
amine and require a heat dependent reaction to complete the crosslinking process, like observed for the 
primary alcohol when using DEG as crosslinking agent. SMA was thus reacted with 10 molar percent of 2-
amino-2-methyl-1-propanol as seen in Scheme 4.3, an agent that contains both a primary amine as well as a 
primary alcohol. During the reaction process however, the SMA crosslinked and was not soluble in water or 
organic solvents. This meant that the same electrospinning procedure as for DEG as crosslinker could not be 




Scheme 4.3: SMA crosslinked with 2-amino-2methyl-1-propanol 
SMA crosslinked with DEG was thus used as the hydrogel mat for further studies as it was the easiest to 
produce and still had soft and pliable characteristics after crosslinking and hydrolysis. 
4.3. Electrospinning of sodium alginate and subsequent hydrogel formation 
The optimum voltage, needle tip to collector plate distance, feed rate and concentration of alginate was 
determined in order to electrospin sodium alginate.   
Sodium alginate, poly(ethylene oxide) (PEO) and Triton-X 100 (a surfactant) were dissolved in distilled 
water in different ratios. The optimum ratio of alginate:PEO:surfactant was found to be 4 wt %:4 wt %:2 wt 
% (with a total solids concentration of 10 wt %) in solution as this was the only solution that yielded uniform 
fibres. 
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Table 4.2: Electrospinning conditions of sodium alginate 
Collector distance (cm) Voltage (kV) Flowrate (mL/min) 
15 15 0.008 
 
The nanofibrous mat was then ionically crosslinked by soaking the mat in ethanol for 1 minute, followed by 
soaking for 10 seconds in a 2 wt % calcium chloride solution in 1:5 ethanol/water. The crosslinked mat was 
lastly rinsed in water for 1 minute. The stability of the mats was then determined by soaking the mats in 
distilled water without agitation for up to one week at room temperature.  
4.4. Water absorption studies 
After the electrospinning and crosslinking of both the SMA and alginate nanofibrous mats, the water 
absorption of both was determined. Five 11 cm squares of each of the mats were cut out and the mats were 
submerged in a PBS buffer with pH of 7.4 as this mimics physiological conditions.  
The squares were submerged in excess PBS buffer for up to 24 h at room temperature without agitation for 
absorption measurement. The mats were removed and free PBS on the surface was removed by placing on 
filter paper.  





Equation 4.2: Absorption ratio, where mw is the mass of the wet mat and md is the mass of the dry mat 
 
Table 4.3: Absorption ratios of five 11 cm strips of SMA after 24 hrs in PBS buffer 
mw (mg) md (mg) R 
76.8 9.8 6.84 
56.7 6.2 8.15 
103.2 9.3 10.1 
100.4 10.8 8.30 
81.8 7.8 9.49 
  Average= 8.57 
 
Table 4.4: Absorption ratios of five 11 cm strips of alginate after 24 hrs in PBS buffer 
mw (mg) md (mg) R 
212.0 8.5 23.9 
175.6 10.7 15.4 
400.9 11.9 33.7 
643.6 10.7 59.1 
775.6 12.8 59.6 
  Average= 38.4 
 
From Table 4.3we see that SMA can on average absorb over 800% its own weight in water, whilst Table 4.4 
indicates that alginate can absorb over 3800% its own weight in water. The ability of SMA and alginate to 
absorb large quantities of moisture in its fibrous form may be tentatively ascribed to the large surface to 
volume ratio exhibited by nanofibres obtained from electrospinning. However, a better conclusion on the 
ability of SMA and alginate to absorb moisture can be drawn if the same material was subjected to water 
absorption studies in its different forms (e.g. film or a solid). 
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Figure 4.2: SMA water absorption of four 1×1 cm strips over time. 1 = 0.0225 g dry mass, 2 = 0.0151 g 
dry mass, 3 = 0.0219 g dry mass, 4 = 0.0144 g dry mass 
In Figure 4.2 we see the absorption behaviour of SMA in PBS over time. Looking at the individual data 
points of Figure 4.2 it is difficult to draw a proper idea of the water absorption behaviour of SMA over time; 
however a general exponential growth curve is seen. Fitting the best curve through the data points, a better 
picture of water absorption comes to light: we see that all fibre mats show exponential uptake of water up to 
around 45 min, after which the uptake plateaus. From the masses of the dry fibre squares, we would expect 
samples 1 and 3 and samples 2 and 4 to exhibit roughly the same behaviour. This is true as can be seen in 
Figure 4.2 above. The plateauing of the curves can be ascribed to the fibres reaching an equilibrium state at 
which point no further water uptake is associated with the polymeric fibres. There however still lies the 
possibility for water to be trapped in the pores between the fibres. It is therefore possible to ascribe the 
deviation from the expected trend to the possible entrapment of water in the pores of the fibrous mat before 
the weighing process to determine the mass of water uptake, as the fibre mats are placed on filter paper to 
remove excess water. Another possible explanation for the deviation is that during the process of removing 
excess water on filter paper, some of the swollen hydrogel fibres (now very soft and gel-like) got stuck to the 
filter paper. This means possible loss of fibres or even addition of paper fibres upon removal to weigh. 
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Figure 4.3: Water absorption of four 1×1 cm strips alginate over time. 1 = 0.0085 g dry mass, 2 = 
0.0077 g dry mass, 3 = 0.0107 g dry mass, 4 = 0.0128 g dry mass 
Figure 4.3 represents the water absorption behaviour of alginate over time. From Figure 4.3 we see that 
alginate follows the same general trend as seen for SMA in Figure 4.2. If we also draw the best fitted curve 
through the data points we see an exponential growth curve that plateaus around 3-4 hours of water uptake. 
The same reasoning as for the SMA hydrogel can be used in terms of the deviations seen: water trapped 
within the pores of the nanofibrous mats affect the weight of the fibre mat as well as the fibres sticking to the 
filter paper. In the case of the alginate hydrogel, the time between measurements were also extended. This is 
due to the soft nature of the wet hydrogel. Excessive handling of the alginate caused the hydrogel to slowly 
break apart. The time elapsed between measurements were thus extended to minimise damage caused when 
handling the wet fibrous mat with tweezers. 
4.5. Electrospinning of qSMI  
In a typical procedure for the preparation of qSMI fibres, 28 wt% SMI (for both SMI-qC8 and SMI-qC12) was 
spun from a 1:1 DMF:THF solution. 
Table 4.5: Electrospinning conditions of qSMI 
Collector distance (cm) Voltage (kV) Flowrate (mL/min) 
15 15 0.011 
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The nanofibrous membrane was put in an oven at 120 °C overnight to allow crosslinking of the fibres. Heat 
treatment rendered the fibres insoluble in water as well as organic solvents. 
The qSMI fibres were firstly spun onto the aluminium collector plate following the procedure described 
above and then heat treated at 120 °C overnight to render them insoluble. This was then followed by the 
electrospinning of an alginate solution containing alginate:PEO:Triton-X 100 in a ratio of 4 wt %:4 wt %:2 
wt % on top of the qSMI fibres. In the second case, qSMI and SMA were spun one onto the other following 
the procedures described in Sections 4.2 and 4.5, followed by heat treatment at 120 °C to render both layers 
insoluble in water and organic solvents. In the case of the alginate and qSMI bi-layered systems, the choice 
to electrospin qSMI and heat treat the fibres, followed by electrospinning of alginate on top of the heat 
treated qSMI, stemmed from an earlier observation when both layers were electrospun onto one another 
before heat treatment as heat treatment burned the alginate fibres. Upon closer inspection, the SMA and 
qSMI fibres adhered to one another; however it was possible to pull the layers apart. The adhesion between 
these layers may simply be due to how the fibres collected onto the same collector plate, as no heat treatment 
took place between spinning, thus allowing for possible fusion of the layers. The ability to pull apart the fibre 
layers however may be ascribed to the brittle nature of SMA. The alginate and qSMI fibres also adhered to 
one another during the spinning process, but not to the same extent as in the case of SMA. This may be due 
to the difference in the production process. 
4.6. Scanning Electron Microscopy (SEM) imaging  
Scanning electron microscopy (SEM) was done on the electrospun fibres described in Sections 4.2, 4.3 and 
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Figure 4.4: SEM imaging of fibre mats: a) SMA at 3000x magnification, b) uncrosslinked alginate at 
3000x magnification, c) SMA at 5000x magnification, d) crosslinked alginate at 3000x magnification, e) 
SMI-qC12 at 3000x magnification and f) SMI-qC8 at 3000x magnification 
 
Figure 4.5: SMI qC8 at 2500× magnification before heat treatment 
From Figure 4.4 above, SEM imaging revealed mostly uniform fibre mats. Figure 4.4 d) revealed that after 
crosslinking of alginate with Ca
2+
-ions, the nanofibrous structure collapses somewhat. This is expected as the 
crosslinking process takes place in a solution consisting of 1:5 ethanol:water. Water is a known solvent for 
alginate and we can thus conclude that the alginate fibres start to dissolve somewhat during the crosslinking 
c) d) 
e) f) 
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process. The final hydrogel mat however does not seem to be affected by this, as it is still able to absorb 
water and does not dissolve even when submerged in water for up to 7 days. In Figure 4.4 f) we notice fusion 
of the nanofibres. The nanofibrous structure does not look fused before heat treatment, as seen in Figure 4.5. 
This may simply be due to heat treatment that rendered these fibres insoluble in water and organic solvents. 
It may also be possible that the fibres were not sufficiently dry before heat treatment. It is however difficult 
to ascribe this phenomenon to crosslinking, as crosslinking  takes place on molecular level and can thus not 
be visualised by means of SEM imaging and therefore we tentatively name it fusion. 
Table 4.6: Average fibre diameter of each electrospun polymer and their standard deviation 
Fibre mat Average fibre diameter (nm) Standard deviation 
SMA 310.4 80.2 
Uncrosslinked alginate 233.2 70.7 
SMI-qC8 429.1 142.8 
SMI-qC12 692.8 173.4 
Fibre diameter was determined by taking an average of 100 fibre diameter measurements per sample. The 
standard deviation was calculated using Microsoft Excel. From Table 4.6 it is interesting to note the average 
fibre diameters in the sub-micron range. We also note that SMI-qC8 has a smaller fibre diameter than that of 
SMI-qC12. For both electrospinning solutions the concentration was kept as 28 wt%. During the process of 
dissolving the polymers, SMI-qC12 took longer to dissolve. It may therefore be possible for the SMI-qC12 
solution to be more viscous and therefore producing fibres with a larger diameter. As fibre diameter is also 
dependent on the applied voltage and distance to the collector plate, the possibility exists that the applied 
voltage was not sufficiently high enough or the distance to the collector plate not far enough to obtain thinner 
fibres. 
4.6.1. Scanning Electron Microscopy (SEM) characterisation details 
Analysis was done on a LEO 1450 VP SEM equipped with a secondary electron detector, variable pressure 
secondary electron detector, backscattered electron detector, energy dispersive X-ray spectrometer, 
cathodoluminescence and wave dispersive X-ray spectrometer. Each fibre mat was cut into 0.5 cm  0.5 cm 
squares and stuck onto a SEM stub using double sided carbon tape to ensure proper conductivity between the 
stub and the sample. The samples were sputter-coated with gold under vacuum before the SEM imaging 
process. Once the SEM images were obtained the images were analysed to determine fibre diameter using 
SEM Image Studio. An average of 100 fibre diameters per sample were measured. The average fibre 
diameter and standard deviation were then calculated using Microsoft Excel and summarised in Table 4.6.   
4.7.  Conclusions 
Uniform nanofibres could be produced from synthetic polymers, namely SMA, SMI qC8 and SMI qC12 as 
well as a natural polymer, namely sodium alginate, using the single needle electrospinning technique as 
could be confirmed using SEM (Figure 4.4). The fibre diameter of the individual fibres is summarised in 
Table 4.3. After electrospinning, SMA and alginate could then be successfully crosslinked by either a heat 
activated crosslinking agent like in the case of SMA or a divalent cation, like in the case of alginate. The 
crosslinked SMA and alginate fibres were then submerged in PBS over 24 hours in order to determine the 
absorption ratio of the hydrogels formed when subjected to moisture. It was found that SMA had an average 
R-value of 8.57 for five 1×1 cm strips submerged in PBS for 24 hours, whilst alginate had an average R-
value of 38.4. Absorption behaviour of SMA and alginate in PBS over time was also studied. From Figure 
4.2 it was noticed that SMA reached equilibrium absorption at around 45min, whilst in Figure 4.3 it was 
noticed that alginate reaches equilibrium at around 3-4 h. Bi-layered systems containing qSMI and either 
SMA or alginate were also electrospun. It was however found that the layers could be removed by simply 
pulling them apart.  
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Chapter 5: Antimicrobial evaluation 
5.1. Introduction 
In the biological world, a question frequently asked when working with microbes, and probably the most 
important question, is “Are the microbial cells dead or alive?” In extreme cases, like for example in 
biological terrorism, the pathogenic viability is of great importance given the possible dire outcome to 
humans when exposed to a viable organism. The viability of a microbe is thus important in order to 
determine the risk related to exposure to a pathogenic microbe. Traditionally bacterial viability is determined 
by plate count
1
. This method however underestimates the real viability of a microbial colony as it only 
expresses the portion of the colony can undergo cell division in selected culture conditions. There are 
however three stages of cell viability, namely: viable, nonviable but resuscitable, and nonviable
1
. Sub-
degrees of viability of individual cells may also exist due to stress caused by starvation or injury. These sub-
degrees would however not be detectable using a plate culture method. One can thus encounter microbes in a 
viable but nonculturable state and other viable cells that do not reproduce in an environment. 
Today various aspects of bacterial vegetative-cell viability can be tested by utilising fluorescent dyes. 




This chapter thus presents an antimicrobial evaluation of the electrospun fibres prepared in Chapter 4. The 
antimicrobial activity of the electrospun fibres was examined against Staphylococcus aureus, a Gram-
positive bacterium, and Pseudomonas aeruginosa, a Gram-negative bacterium. The evaluation utilised 
fluorescence imaging as well as zone inhibition studies on agar plates.  
5.2. Evaluation with Fluorescence Imaging 
Fluorescent microscopy has shown to be a rather useful tool in evaluating cell viability in terms of toxicity 
and antimicrobial activity
2, 3
. The use of different fluorescent dyes that stain target cell constituents, like 
RNA, DNA and nucleic acids, makes fluorescent imaging a versatile technique. Commercially available kits 
commonly used to differentiate between viable and nonviable cells are known as “LIVE/DEAD” BacLight 
Bacterial Viability kits. “LIVE/DEAD” stains are used to determine viability as a function of the membrane 
integrity of a microbial cell
1, 4
. It is therefore possible to monitor the lysis process by determining the number 
of intact cells as well as the number of permeable cells at different time points, utilising these commercially 
available florescent stains
4
. Confocal fluorescence microscopy was thus done on all samples to determine 
antimicrobial activity of the fibres. 
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Figure 5.1: Confocal fluorescence imaging of Staphylococcus aureus exposed to electrospun fibres: a) 
Live control, b) Dead control, c) SMA, d) Alginate, e) SMI qC8, f) SMI qC12, g) SMA and SMI qC8, h) 
SMA and SMI qC12, i) Alginate and SMI qC
8
, j) Alginate and SMI qC12 
 
Figure 5.1 above shows the fluorescent images of Staphylococcus aureus exposed to the different 
electrospun fibres. The images were taken within 2-4 hours of exposure to the fibres. In the images seen in 
Figure 5.1 c) and d) we see that neither sodium alginate nor SMA show any antimicrobial activity towards S. 
aureus as the overall majority of organisms are green in colour, indicative of viable cells. In Figure 5.1 e) we 
see that some of the cells are green, indicating viability, whilst some others are red and orange. The yellow 
arrow in Figure 5.1 e) points to a cell where one can see a red edge with an orange internal colour. This can 
be explained as follows: as the cell wall of the organism loses its integrity the red fluorescing PI dye can now 
enter the cell and stain the internal structures of the cell. The orange colour is thus due to this increase in red 
fluorescing PI in the internal structures of the organism. In Figure 5.1 f) we see the fibrous structure of the 
SMI qC12 mat. We can see a clump of cells that fluoresces red. This indicates that the cells present on the 
fibrous mat are nonviable. We can thus conclude that the SMI qC12 fibres exhibit greater antimicrobial 
activity against S. aureus as compared to SMI qC8. This is in agreement with what was found by Bshena
5
 in 
2012 where he indicated that SMI quaternised with longer aliphatic chains exhibited a greater antimicrobial 
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Figure 5.2: Confocal fluorescence imaging of Pseudomons aeruginosa exposed to electrospun fibres: a) 
Live control, b) Dead control, c) SMA, d) alginate, e) SMI qC8, f) SMI qC12, g) SMA and SMI qC8, h) 
SMA and SMI qC12, i) Alginate and SMI qC
8
, j) alginate and SMI qC12 
Figure 5.2 above shows the fluorescent images of Pseudomonas aeruginosa exposed to the different 
electrospun fibres. The images were taken within 2-4 hours of exposure to the fibres. In the images seen in 
Figure 5.2 c) we see that all cells present on the SMA are green in colour, indicating that they are still viable. 
Figure 5.2 d) on the other hand has both red and green cells present on the alginate mat. It is not expected 
that sodium alginate has any antimicrobial activity towards P. aeruginosa. It may however be due to natural 
cell death, seeing as in a normal colony both viable and nonviable cells are present. It may also be due to the 
cells not being in a nutrient rich environment anymore. In Figure 5.2 e) towards the bottom of the image the 
magenta arrow indicates some viable cells on the SMI qC8 fibre. The yellow arrow in the middle of the 
image points to a clump of red cells, indicating nonviability. In Figure 5.2 f) we see the fibrous structure of 
the SMI qC12 mat. We also see green viable cells present on the fibres of the SMI qC12 mat. Most of the cells 
however are red, and thus not viable. The same antimicrobial behaviour is seen for SMA and alginate in 
combination with SMI qC8 and SMI qC12 in Figure 5.2 g)-j).  
5.3. Zone inhibition on agar plates 
Evaluation of antimicrobial activity by zone inhibition is a common, straight-forward method used in the 
biological field. Simply put, organisms are grown on growth media and subjected to some kind of 
antimicrobial agent, whether it is an antibiotic
6, 7
 or another microbe
8
 that inhibits the growth of a second 
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where no growth around the antimicrobial agent will be present. This simple technique is thus a favourable 
method to also determine the antimicrobial activity of the electrospun fibres prepared in Chapter 4.  
  
Figure 5.3: Zone inhibition plates of Staphylococcus aureus: a) 1: alginate, 2: SMI qC8, 3: SMA, 4: SMI 
qC12; b) 1: SMA and SMI qC8, 2: SMA and SMI qC12, 3: alginate and SMI qC8, 4: alginate and SMI 
qC12.  
In the top left corner of Figure 5.3 a) we see that alginate does not exhibit a clear zone around the fibres 
placed onto the agar plate. This is expected as sodium alginate does not exhibit antimicrobial properties. The 
SMA fibre mat in the bottom left corner of Figure 5.3 a) seems to have a clear zone where no microbial 
growth is present around it. This is not expected as SMA does not exhibit antimicrobial properties. A 
possible explanation for this occurrence may be the presence of NaOH on the SMA mat as a 1.5 M 
NaOH/ethanol solution is used to hydrolyse the SMA nanofibrous mat. In the top right corner of Figure 5.3 
a) we see a distinctly clear zone where no microbial growth is present around the SMI qC8 fibre mat. SMI 
qC12 in the bottom right corner of Figure 5.3 a) exhibits an even larger zone where no microbial growth is 
present. We can thus say that SMI qC12 has a greater antimicrobial effect on S. aureus than SMI qC8, as 
expected from the work done by Bshena in 2012.  
Clear zones where microbial growth is not present can be seen in the case of SMA and SMI qC8 in the top 
left corner of Figure 5.3 b), as well as for alginate and SMI qC8 in the bottom left corner, SMA and SMI qC12 
in the top right corner and alginate and SMI qC12 in the bottom right corner of Figure 5.3 b). Once again the 
double-layered system containing SMI qC12 shows greater antimicrobial activity towards S. aureus than 
those containing SMI qC8, as indicated by the difference in the size of the clear zones about each fibre mat 











Stellenbosch University  https://scholar.sun.ac.za




Figure 5.4: Zone inhibition plates of Pseudomonas aeruginosa: a) 1: alginate, 2: SMI qC12, 3: SMA, 4: 
SMI qC8; b) 1: SMA and SMI qC8, 2: SMA and SMI qC12, 3: alginate and SMI qC8, 4: alginate and 
SMI qC12 
Alginate, in the top left corner of Figure 5.4 a), shows no clear zone where no microbial growth takes place 
around the fibre mat placed onto the agar plate.  It is also interesting to note that the fibrous mat formed a 
hydrogel as seen by the clear colour of the mat and also gel-like consistency upon closer inspection of the 
agar plate. In the bottom left corner of Figure 5.4 a), it seems like there is a clear zone of no microbial 
growth around the SMA fibre mat. This is unexpected, but it may be possible that residual NaOH from the 
1.5 M NaOH/ethanol solution used to hydrolyse the SMA fibres were present on the fibres and caused the 
observed clear zone. Though a bit more difficult to see as compared to SMI qC8 and SMI qC12 in Figure 5.3 
a), we also notice small zones of inhibited microbial growth about SMI qC12 in the top right corner and SMI 
qC8 in the bottom right corner of Figure 5.4 a). It is also not clear which of SMI qC8 and SMI qC12 exhibits a 
greater antimicrobial activity towards P. aeruginosa from the aforementioned figure. 
Clear zones of antimicrobial growth inhibition are also present in the double layered mats of SMA and SMI 
qC8, alginate and SMI qC8 as well as SMA and qC12 as seen in Figure 5.4 b). From the bottom right corner of 
Figure 5.4 b) however it is unclear whether the alginate and SMI qC12 bi-layered mat shows any 
antimicrobial activity. 
5.4. Conclusion 
From the confocal images in Figure 5.1, as well as zone inhibition studies we see that both SMI qC8 and SMI 
qC12 exhibit antimicrobial activity towards Staphylococcus aureus. SMI qC12 exhibits a greater degree of 
antimicrobial activity towards S. aureus as can be seen from the larger zones of growth inhibition seen in 
Figure 5.3 a) and b). The bi-layered systems containing either SMA or alginate with SMI qC12 also exhibits 
greater antimicrobial activity towards S.areaus than SMA or alginate with SMI qC8. This is in agreement 
with what was previously shown by Bshena.  
The confocal images for Pseudomonas aeruginosa in Figure 5.2 also showed that both SMI qC8 and SMI 
qC12 exhibited antimicrobial activity towards P. aeruginosa. This was also seen for the bi-layered systems 
containing either SMA or alginate with SMI qC8 and SMI qC12. It was however difficult to conclude from 
both the confocal images and the zone inhibition plates which of the two quarternised fibres showed greater 
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Interestingly it seemed like SMA exhibited antimicrobial activity on both S. aureus and P. aeruginosa when 
looking at the zone inhibition plates. This however did not correlate with what was seen in the confocal 
images and a plausible explanation is the possible presence of residual NaOH on the fibre mats from the 
hydrolysis procedure which utilises a 1.5 M NaOH/ethanol solution. 
5.5. Sample preparation and microscopy 
Before any antimicrobial testing was done on the electrospun fibres, the fibre samples were placed in a glass 
desiccator containing chloroform overnight in order to sterilise the samples and prevent any contamination 
acquired during the production of the fibres. 
5.5.1. Confocal fluorescence imaging 
Imaging was done on a Carl Zeiss Confocal LSM 780 Elyra S1 (Figure 5.5) with a SR-SIM superresolution 
microscope at the Central Analytical Facility at Stellenbosch University. 
 
Figure 5.5: Carl Zeiss Confocal LSM 780 Elyra S1 microscope used for fluorescent imaging 
For fluorescence imaging, 20 mL Luria-Bertani (LB) media was inoculated with 3-5 colonies of the 
organism (either S. aureus or P. aeruginosa) and grown at 37 °C overnight (16 hours) at 150 rpm at an angle. 
A 200 μL volume of the culture was then transferred to 5 mL of fresh LB media and grown for a further 5 
hours in order to ensure that the cells are in its logarithmic growth phase. The culture was then diluted to an 
optical density (OD) = 0.2 and 10 μL transferred to each of the samples used for imaging.  
Staining of the bacteria was done using a “LIVE/DEAD” BacLight Bacterial Viability kit containing 
Proidium Iodide (PI) and Syto9 dyes. A stock solution of the dyes was made by adding 1μL of each dye to 
1000 μL PBS. Staining was then done by adding 100 μL of the dye stock solution to a well in a sample plate 
containing the fibre mats in individual wells. 
5.5.2. Zone inhibition method 
Twenty mL LB media was inoculated with 3-5 colonies of the organism (either S. aureus or P. aeruginosa) 
and grown at 37 °C overnight (16 hours) at 150 rpm at an angle. The culture was then diluted to an optical 
density (OD) = 0.2 and 200 μL transferred to each of the agar plates. The plates were incubated overnight at 
37 °C after which the plates were inspected for halos, indicating antibacterial growth. 
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Chapter 6: Epilogue 
6.1. General conclusions 
This thesis focused on the design of a bi-layered wound dressing based on antimicrobial polymer. It has been 
shown that a moist wound environment is favourable for healing as it increases healing rates. For this reason, 
a hydrogel was chosen as the first layer of the wound dressing. A hydrogel was then made based on the 
materials already in use for hydrogel dressings, namely sodium alginate. Though sodium alginate dressings 
are usually in the form of a sheet, the object of this study was to electrospin both the hydrogel as well as the 
second antimicrobial layer. A second hydrogel was also introduced in the form of SMA. SMA is an attractive 
polymer due to its chemical and biological properties, wide availability and low cost. SMA is also the parent 
molecule from which the polymeric antimicrobial layer was synthesised and then electrospun to achieve the 
bi-layered wound dressing. 
In Chapter 3 the synthesis and characterisation of SMA using conventional free radical chemistry is 
described. SMA was then successfully modified to yield a SMI precursor, followed by further modification 
with 2 different alkylhalides, namely 1-bromooctane and 1-bromododecane. During the modification of 
SMA to yield the SMI precursor, it was found that at lower modifications (30-60 %) of SMA with DMAPA 
(a compound containing both a primary and tertiary amine) clumping took place. A model study using 1,2-
cis-cyclohexanedicarboxylic anhydride as model compound was devised in order to better understand this 
clumping phenomenon and possibly shed some light on the crosslinking of SMI. The model compound was 
reacted with both DMAPA and TEA. The successful reaction of the model compound with TEA suggests 
that at lower modifications of SMA with DMAPA intramolecular crosslinking reactions take place with the 
tertiary amine group of DMAPA, since the primary amine readily reacts with the anhydride residues of 
SMA. This may also serve as a plausible explanation for the crosslinking of SMI derivatives, like when 
qSMI fibres are heat treated, rendering them insoluble in water and organic solvents. 
Chapter 4 represented the electrospinning process of SMA and its derivatives as well as sodium alginate to 
obtain nanofibres. SMA and alginate were crosslinked by means of a crosslinking agent in the case of SMA 
and a divalent cation (Ca
2+
) in the case of alginate, to yield fibrous hydrogels. The fibrous hydrogels were 
then subjected to moisture in order to determine their water absorption behaviour over time. It was shown 
that SMA has a R-value of 8.57 and reaches equilibrium absorption at around 45 minutes of being 
submerged in PBS. Alginate on the other hand has a R-value of 38.4 and reaches equilibrium absorption at 
around 3-4 hours of being submerged in PBS. Bi-layered systems of the different qSMI fibres with either 
SMA or alginate as hydrogel were also produced. The layers seem to have adhered to one another during the 
electrospinning process, but could be pulled apart.  
Chapter 5 described the antimicrobial activity of the fibres and bi-layered systems produced in Chapter 4. 
The antimicrobial activity was investigated against a Gram-positive bacterium, namely Staphylococcus 
aureus, as well as a Gram-negative bacterium, namely Pseudomonas aeruginosa. Fluorescence imagings 
showed that both SMI qC8 and SMI qC12 as well as the bi-layered systems containing SMI qC8 and SMI qC12 
were able to kill the different bacteria. Zone inhibition of the fibres on agar plates was also studied. It was 
found that SMI qC12 and the bi-layered system containing SMI qC12 exhibited greater antimicrobial activity 
against Staphylococcus aureus than SMI qC8 or the bi-layered system containing SMI qC8. For Pseudomonas 
aeruginosa it was found that both SMI qC8 and SMI qC12 and their bi-layered systems exhibited 
antimicrobial activity. It was however difficult to determine which of the two antimicrobial polymeric fibres 
exhibited greater antimicrobial activity against Pseudomonas aeruginosa. 
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6.2. Future recommendations 
The encouraging results in terms of antimicrobial activity of SMI qC12 against Stahylococcus aureus has 
considerable potential as a wound dressing, considering the widespread occurrence of secondary infection in 
hospitals due to this organism. Further research in terms of toxicity to human cells is required for wound 
dressings containing SMI qC12. The production of hydrogels in nanofibrous form is also an advantageous 
development from this study, as it may minimise problems like adhering to wounds. Further studies in terms 
of moisture absorption capabilities of the different hydrogels in a different form (like film or sheet) should 
also be investigated. Although we know that alginate dressings are already in use, hydrogels from SMA 
should also be evaluated for toxicity and biocompatibility towards mammalian cells.  Study into the 
combined double-layered wound dressing produced in this study should also include investigation towards 
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